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Summary 
Coronary Heart Disease (CHD) is the leading cause of death worldwide and there has been an 
increasing interest in primary prevention. The research field struggles to reach a unified 
agreement about the role of anxiety and depression as etiological variables, and the role of 
anxiety is especially unclear. Inconsistences and contradictory findings can, to a large extent, 
be attributed to a lack of specificity in both predictors and outcome. Identifying psychological 
risk variables is an important step in reducing the number of deaths and disabilities due to 
CHD, especially among women where Myocardial Infarction (MI) often occurs 
asymptomatically.  
The overall goal of this thesis was to investigate if symptoms of anxiety and depression as 
measured by the Hospital Anxiety and Depression Scale, HADS (Zigmund & Snaith, 1983), 
can be used to screen for risk of an incident Myocardial Infarction. Incident MI is defined as 
the individual’s first MI. 
This thesis consists of three papers. Paper I and II were based on data from The Nord-
Trøndelag Health Study (HUNT 2 and HUNT 3). Paper III was based on a sample of 
psychology students. In Paper I, the etiological and prognostic approach is combined to 
identify symptoms of depression and anxiety as causes of MI, and not merely consequences of 
MI. This was done by comparing symptoms of anxiety and depression before and after the 
experience of incident MI. Elevated symptoms of depression measured by HADS increased 
the risk of incident MI. Although limitations apply, having an MI did not have long-term 
adverse effects on the level of anxiety and depression symptoms, and time since MI was not a 
significant predictor of symptom level. 
Furthermore, researchers have requested a focus on women and CHD.  The aim of Paper II 
was to identify gender-specific psychological risk-profiles based on HADS to optimize 
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screening of MI-risk. Gender differences in the MI-risk estimate were identified: elevated 
HADS-D score was a significantly stronger predictor of incident MI among women compared 
to men.  History of depression was a significant predictor of MI among men, but not women. 
This emphasizes the need for gender-specific psychological risk profiles. Elevated symptoms 
of anxiety measured by HADS represented a reduced risk of having an incident MI among 
both men and women.   
In Paper III, the aim was to focus on the content in the HADS, and how the anxiety and 
depression dimension in the instrument were related to more general emotional dispositions. 
The dimensions in HADS presented high test-retest stability and a strong relationship to the 
personality traits neuroticism and extroversion. The two dimensions in HADS could be 
differentiated by the specific relationship between the depression scale, positive affect and 
extroversion. The results supported that HADS-D represent an anhedonic subtype of 
depression.  
The findings in this thesis have implications for the research field on psychological variables 
and CHD as well as the practice of efficient risk-screening. It further substantiates the role of 
personality in symptom reporting.  
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Introduction 
Cardiovascular disease (CVD) is the most common cause of death in Norway (National 
Health Institute, 2014). Identifying psychological risk variables is an important step in 
reducing the number of deaths and disabilities due to CVD. The research field struggles to 
reach a unified agreement on the role of anxiety and depression as etiological variables, due to 
lack of specificity in measurement (Suls & Bunde, 2005; Davidson, 2012; Batelaan, ten Have, 
van Balkom, Tuithof, & de Graaf, 2014; Cohen, Edmondson, Kronish, 2015).  To understand 
the role of symptoms of anxiety and depression in predicting Myocardial Infarction (MI) in 
the general population, we need to (1) identify symptoms of depression and anxiety as causes 
of MI, not only consequence of MI. Furthermore, (2) it is important to identify gender-
specific psychological risk-profiles in order to optimize screening of MI-risk. To identify the 
optimal screening tool and understand the relationship between psychological symptoms and 
MI, (3) there is a need to focus on the content in the specific instrument used, and how 
specific symptoms are related to more general emotional dispositions.   
Depression and cardiovascular diseases 
 
CVD includes two major sub-types: Coronary heart disease (CHD) and cerebrovascular 
disease (stroke).  In CHD, the blood flow to the heart is reduced causing an inadequate 
amount of oxygen to reach the heart tissue.  CHD can cause angina (chest pain), Myocardial 
Infarction (MI) and sudden cardiac death. Based on the 10th Revision of the International 
Classification of Diseases (ICD-10), Myocardial Infarction represents an acute heart failure 
(ICD-10 code 121-122). In Europe and North America, coronary heart disease (CHD) is the 
leading cause of death in the adult population (Yusuf et al., 2004), and several risk factors 
(e.g. smoking, hypertension, cholesterol and diabetes) have been established as effective 
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predictors (Wilson, A’Agistino, Levy, Belanger, Silbershatz, Kannel, 2005). The link between 
psychological variables and CVD is one of the most studied mind-body connections, where 
the role of depression has received most attention. Chronic psychological stress, post-
traumatic stress, and anxiety have also been studied with regards to epidemiologic evidence 
and underlying mechanisms (Cohen, Edmondson, & Kronish, 2015). Depression continues to 
be subject to inquiry; both concerning incident CVD and mortality due to CVD (Carney, 
Freedland, & Sheps, 2004; Mykletun, Bjerkeset, Dewey, Prince, Overland, & Stewart, 2007) 
and as a prognostic factor in CVD patients (e.g. Huffman, Celano, & Januzzi, 2010; Doyle, 
Conroy, McGee, Delaney, 2010). While the prognostic studies focus on patients with existing 
coronary heart disease (CHD), the etiologic approach, on the other hand, focuses on whether 
depression is a risk factor for incident coronary heart disease in the general population. A 
substantial amount of the research on depression and CVD focuses on e.g. reinfarction and 
mortality in CVD patients (e.g. Doyle et al., 2015; Cohen et al., 2015), or depression in MI 
patients (e.g. Hanssen, Nordrehaug, Eide, Bjelland, & Rokne, 2009; Benyamini, Roziner, 
Goldbourt, Drory, & Gerber, 2013). The etiological approach has received less attention, 
unfortunately. However, integrating the two approaches could be beneficial. A review of 
studies examining the contribution of depression to the onset of coronary diseases has 
concluded that depressive symptoms contribute as a significant independent risk (Wulsin & 
Singal, 2003). A more recent systematic review and meta-analysis of depression and risk for 
CVD (Van der Koy, Hout, Marwijk, Marten, Stehouer, & Beekman, 2007) support the 
possible link, but emphasize that solid evidence for this relationship is not yet established, as 
the findings are inconsistent. A large meta-analysis of 54 observational studies concludes that 
depression is not established as an independent risk factor for CHD (Nicholson, Kuper, 
Hemingway, 2006). Two more recent reviews on the evidence of depression being a risk 
factor for CVD conclude that the evidence is not sufficient to suggest that depression is an 
11 
 
independent causal risk factor for incident CVD or CHD (Stampfer, Hince & Dimmit, 2012; 
Hare, Toukhsati, Johansson, Jaarsma, 2014).  
However, both previous and current research propose a relationship between depression and 
CVD, a notion further supported by the inclusion of both anxiety and depression as risk 
factors in guidelines on CVD prevention (Gan et al., 2014; Perk et al., 2012; Glozier, et al. 
2014). A review of prospective studies on depression as a risk factor of CHD points to 
substantial heterogeneity in risk estimate, especially those where self-report depression scales 
have been applied (Gan, et al., 2014). To improve the understanding of the nature of the 
relationship between symptoms of depression and CHD, one should aim at a high level of 
specificity in both predictor and outcome.  Frequently, the literature does not differentiate 
between stroke and CHD, and hence CVD will be addressed as a general category several 
times in this introduction. However, the outcome of interest in this thesis is CHD, specifically 
Myocardial Infarction. Furthermore, there are different subtypes of depression, and some may 
be more relevant than others in this particular context.  
The aim of this study is to address the role of anhedonic depression, which can be considered 
a specific depression sub-type, and an independent risk factor of incident MI when other risk 
factors as well as anxiety are included in the equation.  In addition, the role of dispositional 
factors in terms of personality traits will be addressed in order to explore the complex 
relationship between affect and cardiovascular health, as it is suggested that personality and 
psychopathology share common biological and environmental developmental processes 
(Clark, 2005).   
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What causes Myocardial Infarction? Traditional and established risk factors  
 
This thesis focuses on psychological variables, namely the self-report of symptoms of anxiety 
and depression using a specific instrument; the Hospital and depression scale; HADS 
(Zigmond and Snaith, 1983). Here, the HADS anxiety and depression subscales are 
investigated as  independent risk factors of Myocardial Infarction (MI). Many studies 
included in meta-analysis of the relationship between depression and MI do not adjust for 
other risk factors (Nicholson et al., 2006), but depression can only be established as an 
independent risk factor when all major traditional risk factors are included and controlled for. 
Several risk scores has been developed. The Framingham risk score (Anderson, Odell, 
Wilson, & Kannel, 1991) and the European Society of cardiology systematic coronary risk 
evaluation (SCORE system) (Conroy, Pyorala, & Fitzgerald, 2003) both include six major 
risk factors of CHD, i.e., gender, age, systolic blood pressure (SBP), cholesterol, history of 
diabetes and smoking. The INTERHEART study investigated cases of first MI from 52 
different countries, identified nine modifiable risk factors along with gender and age globally 
associated with MI. These were apolipoprotein (ApoB, or “bad cholesterol”) levels, smoking, 
hypertension, diabetes, abdominal obesity, psychosocial factors, dietary factors, physical 
exercise, and alcohol consumption. Several other factors are associated with increased risk of 
MI, such as family history of heart disease and physical activity, but these factors work to a 
large extent through the other major risk factors (Wilson et al., 1998). In the development of 
the INTERHEART modifiable risk score, the final version did not include psychosocial 
variables like stress and depression, as they did not improve discrimination (McGorrian et al., 
2011). This advocates a further investigation of the role of depression as an independent risk 
factor. 
13 
 
Is depression a cause or effect of MI, or simply a correlate to other risk 
factors? 
It is uncertain whether “emotional triggers could initiate a paradigm shift in preventive 
cardiology, or whether acute emotional triggers are either intractable catalysts for or merely 
an epiphenomenon of MI” (Edmondson, Newman, Whang & Davidson, 2011, p. 300). 
Symptoms of depression vary with age (Faravelli, Scarpato, Castellini, & Sauro), gender 
(Faravelli et al., 2013; Altemus, Sarvaiya, & Epperson, 2014), obesity (e.g. Svenningson, 
Björkelund, Marklund & Gedda, 2011), hypertension (Meng, Chen, Yang, Zheng, & Hui, 
2012), health behaviors like smoking and drinking (Benyamini et al., 2013) and health status, 
like being a cardiac patient (Doyle et al., 2015). A recent clinical review by Hare and 
colleagues (2014) points to the important distinction between depression being a risk factor, 
versus a risk marker, of CVD. It is argued that the causal relationship between depression and 
CVD is not established and that many different mechanisms might be biologically plausible 
(e.g. genetic linkage to serotonin transporter mechanism, platelet function) as well as behavior 
aspects like poor adherence to medical treatment (Baune, Stuart, Wersching, Heindel, Arolt, 
& Berger, 2012; Edmondson et al., 2013). Some have argued that the association is reversed; 
i.e., that there is a cardiovascular contribution to the etiology of depression (Åberg et al., 
2012). Although there is a general agreement that depression is associated with worsened 
prognoses in cardiac patients (e.g. Cohen et al., 2015), the communication between the 
prognostic and etiological field has been scarce. Leung and colleagues (2012) have made a 
request for studies that separate pre-morbid and post-morbid depression in MI patients. Very 
few studies take into account that elevated symptoms of depression might represent a more 
dispositional tendency to experience negative emotions, a tendency that is closely linked to 
personality trait. Lack of consistent findings on the effect on treatment of depression in order 
to improve prognosis in cardiac patients (Vieweg, Hasnain, Lesnefsky, & Pandurangi, 2011; 
Thombs et al., 2013) might suggest that depression is more important as a risk marker of 
14 
 
CVD, but equivocal results are lacking within the field.  Several meta-studies and reviews on 
the role of depression as an etiological factor in the development of CVD (e.g. Nicholson et 
al., 2006; Stamfer et al., 2012) have reached the same conclusion: Heterogeneity in 
measurement and lack of control of confounding variables prevent firm conclusions.   
What do depression scales measure?  
The European guidelines on cardiovascular disease prevention in clinical practice (Perk et al., 
2012) recommend that anxiety and depression be included in the risk assessment of CHD. 
However, the guidelines do not specify what types of screening or instruments to apply. 
Although a clinical diagnostic interview is considered the golden standard, self-report 
measures of depression are both more cost-effective and easy to administrate. It is beyond the 
scope of this study to make a thorough discussion of the diagnostic criteria of depression (e.g. 
DSM-V vs DSM-IV, and ICD-10); therefore, the focus is on how and why some self-report 
scales of depression might be better at detecting risks than others.  Snaith (1993) has 
addressed the question outlined in the heading and concluded that “The measurement of 
depression is as confused as the basic construct of the scale itself” (Snaith, 1993, p. 296). 
In the prognostic field, the inaccurate measurement of depression has been suggested as the 
reason treatment of depression fails to improve the prognosis of MI patients (Vieweg et al., 
2011; Thombs et al., 2013). In the etiological approach, inconsistent operationalization of 
depression might explain the substantial heterogeneity and, at times, conflicting findings.  
Different types of depressive symptoms and clusters differ in their prognostic value in persons 
with CHD and hence, considering depression as a multidimensional disorder in research on 
CHD has been requested (Schaffer, Whang Shimbo et al., 2012; Hawkins, Callahan, Stump, 
& Stewart, 2013; Stewart et al., 2012; Doyle et al., 2010; Baune et al., 2012).  To detect risk 
of recurrent CHD, the use of more specific sub-types, or intermediary phenotypes of 
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depression have been suggested (Shaffer et al., 2012). The confusion in the operationalization 
of depression has hampered the research on the link between depression and CVD (e.g. 
Davidson, 2008; Davidson et al., 2005). During the last half decade there has been a 
significant increase in the literature addressing the inconsistencies and problematic issues 
concerning depression measurement (Chen, Eaton, Gallo, & Nestadt, 2000; Fried, Nesse, 
Zivin, Guille&  Sen, 2014; Fried, 2015; Fried & Nesse, 2015). In the recent meta-analysis by 
Gan and colleagues (2014) on prospective studies on depression and the risk of CHD, the 
suggestion for further research emphasizes that investigators should strive to improve the 
standardization of depression measurement. Fried and Nesse (2015) point to how depression 
is treated as a homogeny unit, although few would agree that it is. Adding up different 
symptoms into one categorical unit labeled “depressed” has hampered the research on 
depression for understanding the risk factor of depression and developing effective treatment.    
The dissatisfaction with the non-specificity of major depression has led many to propose more 
specific depressive subtyping models. Subtyping depression is a promising attempt to 
overcome the non-specificity of major depression, and this has an implication for treatment-
specification (Baumeister & Parker, 2012). Fried (2015) argues that the focus on syndromes 
instead of symptoms has slowed down research on depression, and that the clear-cut 
“depressed vs. non-depressed” is based on the unweighted adding of diverse symptoms (e.g. 
sad moods, fatigue, anhedonia, sleep disturbance). The category “depressed” constitutes a 
rather heterogeneous group with a substantially different although overlapping, symptomatic 
profile. Furthermore, the substantial overlap between depression and anxiety adds to the 
complexity.  
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Anxiety and CVD 
Comorbidity of anxiety and depression, both in terms of symptom reporting and diagnosis is 
prevalent from childhood (Cummings, Caporino, & Kendall, 2014). Although the status of 
anxiety as a risk factor of CVD is not as established as depression (Albus, 2010; Cohen et al., 
2015), the European guidelines of CVD prevention suggest screening of anxiety and 
depression to identify those at risk (Perk et al., 2012). During the last decade, there has been 
an increased focus on the connection between anxiety and the development of CHD (Roest, 
Martens, Jonge, & Denollet, 2010; Tully, Cosh & Baune, 2013; Batelaan et al., 2014). 
However, as with depression, the various conceptualizations of anxiety have hampered the 
understanding.  Seldenrijk and colleagues (2015) recommends a focus on diagnostic subtypes 
of both depression and anxiety in predicting CVD risk. The meta-analysis by Roest and 
colleagues (2010) is probably the most cited in the research on anxiety as a risk factor of 
incident CHD. However, it has been pointed out that the meta-analytic estimate was not 
adjusted for depression (Cohen et al., 2015). In the work by Janszky and colleagues (2010), 
early onset of anxiety was more important than early onset of depression. The sample 
consisted of men only, and depression was operationalized by the category “psychotic and 
neurotic depression” (ICD-10).  
While some have found that worry and generalized anxiety disorder (GAD) is associated with 
mortality (Tully et al., 2011; Watkins et al., 2013), other studies have demonstrated that 
symptoms of anxiety are negatively associated with CHD mortality (Meyer, Buss, & 
Herrmann-Lingen, 2010; Mykletun et al., 2007; Walters, Rait, Petersen, Williams, & 
Nazareth, 2008). Further, generalized anxiety disorder (GAD) has been found to predict 
superior outcome after acute coronary syndrome (Parker, Hyett, Hadzi-Pavlovic, Brotchie, & 
Walsh, 2011). In CHD patients, elevated symptoms of anxiety operationalized by HADS 
(Zigmund & Snaith, 1983) were positively associated with survival and reduced the risk of 
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cardiac events (Meyer, Hussein, Lange, & Herrmann-Lingen 2015). Other studies have found 
that anxiety is not associated with CHD events when depression has been controlled for 
(Versteeg et al., 2013). To understand the role of anxiety as well as depression as risk factors 
of incident CVD, the level of specificity in the predictors and outcome needs to be high. The 
control of confounding variables and established risk factors also need to be included, and 
both measures of anxiety and depression should be included to rule out the possibility of 
comorbid confusion. Watson and colleagues (1995) note that in regard to anxiety and 
depression scales, there seems to be little consistency in which the respective scales of 
different symptoms should be associated with, and that many scales that measure depression 
include symptoms that are more appropriate to anxiety and vice versa. In addition, 
comorbidity between anxiety and depression varies depending on the specific anxiety disorder 
(Cummings et al., 2014).  Methods that can adequately differentiate between depression and 
anxiety are crucial (den Hollander-Gijsman et al., 2012) and understanding the shared and 
distinctive features of the two constructs is important.  
 
The Tripartite model of anxiety and depression and HADS 
In 1991, Clark and Watson proposed the tripartite model of anxiety and depression. In the 
tripartite model, symptoms are grouped into three subtypes: The two basic dimensions, 
negative affect (NA) and positive affect (NA), and a third factor, physiological hyperarousal. 
In this model, a general dimension that represents negative affect is common for both anxiety 
and depression, while a lack of positive affect; anhedonia, is specifically related to depression. 
Somatic tension; physiological hyperarousal, is specific to anxiety (Fig 1.).  This tripartite 
model gives an account of the symptom overlap and diagnostic comorbidity between anxiety 
and depression and has made significant contributions to understanding anxiety, depression 
and general mood disorders. Clark and Watson (1991) argue that the different combinations 
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of these three scales will facilitate differentiation of depression and anxiety disorders in 
patients. This tripartite model posits that anxiety and depression share a common component 
of negative affect, but can be differentiated by low positive affect associated with depression. 
The structure of the model has been validated in different samples across age and health status 
(Watson et al., 1995). Although it has received criticism due to a lack of specificity within 
anxiety and depression disorders (e.g. den Hollander-Gijsman et al., 2012), it provides a 
useful theoretical framework for understanding how to discriminate between anxiety and 
depression in self-report scales (Dunbar, Ford, Hunt, & Der, 2000).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The tripartite model of anxiety and depression (Clark & Watson, 1991) 
Physiological 
hyperarousal 
Positive affect Negative 
affect 
Anxiety Depression 
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The Hospital Anxiety and Depression Scale  
Few measures of symptoms of anxiety and depression have received the same amount of 
attention as the Hospital and Anxiety Depression Scale (HADS). In an updated literature 
review, Bjelland and colleagues (2002) concluded that the concurrent validity of HADS is 
good to very good, based on the available correlations between HADS and instruments like 
BDI, general health questionnaire (GHQ), Spielberg State and Trait Anxiety Inventory 
(STAI), and Montgomery-Aasberg Depression Rating Scale (MADRS). However, several 
analyses, review articles and meta-analysis have been performed since then. While Bjelland 
and colleagues (2002) conclude that HADS presents satisfactory structural properties, others 
claim that the factorial structure of HADS is unclear, depending on the statistical methods 
applied and characteristics of the sample (Caci, Baylè, Mattei, Dossios, Robert & Boyer, 
2003; Cosco, Doyle, Ward & McGee, 2012). In 2012, Coyne and Sonderen wrote an article 
entitled “No further research needed: abandoning the Hospital and Anxiety Depression 
Scale.” The article was a comment to the 10-year systematic review of HADS made by Cosco 
and colleagues (2012). The main argument for abandoning HADS was that the review 
concluded that the psychometric properties of HADS varied across samples and the statistical 
approach applied.  Others have argued that the HADS is important (Doyle, Cosco, Conroy 
2012; Norton, Sacker & Done, 2012). Compared to BDI, HADS-D identifies fewer cases of 
depression in MI patients (Bush et al., 2005), and the accuracy of HADS-D in detecting 
depression in groups in general has been questioned (Nowak et al., 2014). Recent large-scale 
studies advocate that HADS should be used as a general measure of distress instead of two 
separate measures of anxiety and depression (Norton, Cosco, Doyle, Done, & Sacker, 2013; 
Burns, Höfer, Curry, Sexton, & Doyle, 2014). Further, the cross-cultural validity of HADS 
has been questioned because some of the items are not transferable culturally or 
geographically (Maters, Sanderman, Kim, & Coyne, 2013).  
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 However, some have argued that there is a need to focus on the content in HADS (Doyle, 
Cosco, & Conroy, 2012; Straat, van der Ark, & Sijtsma, 2013). Despite wide criticism (e.g. 
Coyne, & van Sonderen 2012), HADS has received renewed attention in the field of cardiac 
research (e.g. Doyle, McGee, Harpe, Shelley & Conroy, 2006; Damen, Pelle, Boersma, 
Serruys, Domberg & Pedersen, 2012; Pelle, Pedersen, Erdman, Kazemier, Spiering, 
Domburg, & Denollet, 2011; Gustad, Laugsand, Janszky, Dalen, & Bjerkeset, 2013; Meyer et 
al., 2015).  
Few studies have directly questioned the content validity of the HADS scale, although the 
dominant focus on anhedonia in the depression sub-scale has been noted: “important 
components of depression, such as hopelessness, guilt, and low self-esteem, are not assessed 
because the HADS-D focuses mainly on anhedonia” (Mykletun, Stordal, Dahl, 2001, p. 543). 
While the HADS anxiety scale contains items that are concerned with worrying, restlessness 
and panic attacks, the HADS depression scale focuses on anhedonic depression, i.e., lack of 
positive affect.  Clark and Watson (1991) proposed that the anhedonic content in the HADS 
depression scale represents the “Low positive affect scale” in the tripartite model. In addition,  
using an abbreviated version of the HADS-D scale as a measure of reduced positive affect 
(anhedonia) has been observed in the prognostic approach (e.g. Denollet et al., 2007; Pelle et 
al., 2011; Damen et al., 2012).  
Anhedonia 
Anhedonia is a key feature in many psychiatric disorders, and is commonly thought of as 
reduced positive affect. Although viewed as a core symptom in the psychopathology of major 
depressive disorder, as well as included in diagnostic manuals, its measurement in depression 
has received little research attention (Nakonezny, Carmody, Morris, Benji, Kurian, & Trivedi, 
2010). Anhedonia also refers to loss of interest and pleasure, and changes in reactivity to 
stimuli usually experienced as pleasurable.  Rømer-Thomson and colleagues (2015) have 
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argued that anhedonia is more than a reduction in pleasure, and that anhedonia should be 
differentiated into impairments in pleasure, wanting and learning. Neuroscience can play an 
important role in the understanding of the concept (Der-Avakian & Markou, 2012), as 
different positive emotions have different physiological reactions (Kreibig, 2010). In research 
on depression and pharmacological treatment (anti-depressant), there has been an emerging 
interest in anhedonia (Kennedy & Cyriac, 2012; Di Giannantonio & Martinotti, 2012). The 
focus on different subtypes of depression, like anhedonia, has implications for treatment as 
well as diagnoses, as different antidepressants have unique effects on affect reward processes  
(McCabe , Mishor , Cowen, & Harmer, 2010; Kennedy & Cyriac, 2012).  
Positive emotions, Anhedonia and CVD 
Positive and negative states are dependent although not bipolar opposites (Barrett & Russel, 
1999). Although marginalized compared to negative emotions, the idea that positive emotions 
are good for the heart has a long history. Fredrickson (1988) points to how positive emotions 
build social, intellectual, psychological and physical resources. Of physical resources, the 
impact of positive emotions on immune function has shown that positive emotional style 
predicts resistance to experimental exposure to virus (Cohen, Alper, Doyle, Treanor, & 
Turner, 2006). Recent research on amygdala activation suggests that a high level of positive 
affect does not reflect a neglect of negative stimuli, but is rather associated with being better 
equipped to notice and respond appropriately to both opportunity and threat (Cunningham & 
Kirkland, 2014). Cardiovascular health is affected as positive emotions have shown to speed 
recovery from the cardiovascular stress-responses caused by negative emotions (Fredrickson 
& Levenson, 1998). Fredrickson (2000) points to the undoing effect of positive emotions, as 
experimental induced positive emotions made the participant return faster to baseline levels of 
blood pressure, heart rate and peripheral vasoconstriction. In a prospective study, positive 
psychological well-being was associated with a reduced risk of CHD (Boehm, Peterson, 
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Kivimaki, & Kubzansky, 2001) and longevity in general (Diener & Chan, 2011). Shaffer and 
colleagues (2012) address the importance of research on different depression phenotypes, and 
emphasize the role of anhedonic depression in the association between depression and CHD. 
In the search for specific symptom clusters of depression as risk factors of CHD, anhedonia 
was the second most important after the somatic cluster (Hawkins, 2013).  
Anhedonia has received attention both as a prognostic (Denollet, Pedersen, Daemen, de 
Jaegere, Serruys, van Domburg, 2007; Leroy, Loas, & Perez-Diaz, 2010; Damen et al., 2013) 
and an etiological factor (Davidson, Mostofsky, & Whang, 2010). The HADS (Zigmond & 
Snaith, 1983) include no somatic markers, but has been suggested as superior to other 
measurement scales of depression in CHD research because of its focus on anhedonia (Doyle, 
et al., 2012). Recent research has pointed out that positive affect was protective against a 10-
year incident of coronary heart disease when controlling for depression (Davidson et al., 
2010). In regard to stroke, the items of the Center for Epidemiological Studies Depression 
scale (CES-D) that measure positive affect significantly predicted risk of stroke, whereas the 
remaining items of the scale, i.e., negative affect, did not (Ostir, Markides, Peek, & Goodwin, 
2001). Anhedonia has been found to be a predictor of severe cardiac events after acute 
coronary syndromes (Leroy et al., 2010) and after coronary-artery stent implantation 
(Denollet et al., 2007) and among CHD patients, reduced positive affect (anhedonia) is 
associated with mortality (Damen, Pelle, Boersma, Serruys, Domburg, & Pedersen, 2013). In 
the studies mentioned above, anhedonia has been operationalized by four out of seven of the 
items in the depression scale in HADS, and has provided support for the idea that anhedonia 
is independently associated with MI or death in patients with heart conditions. These findings 
from the prognostic approach strongly advocate an investigation of the role of anhedonic 
depression symptoms as predictors for an elevated risk of having an incident MI.   
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Although linked to psychiatric disorders, trait anhedonia is also observed dimensionally in 
healthy individuals, where trait anhedonia was related to limbic and paralimbic systems 
involved in reward processing (Keller et al., 2013). Reward-dependence and positive affect is 
a central aspect of anhedonia, as well as being core components within personality 
psychology. Positive affect is also closely linked to more stable dispositions in experiencing 
positive emotions and reward dependence, and personality traits represent stable, emotional 
tendencies that can predict both frequencies, intensity as well as more pathogen emotional 
experiences (Watson & Naragon-Gainey, 2014; Watson, Stasik, Ellickson-Larew, & Stanton,  
2015). More recent studies move beyond the prior emphasis on negative affect, and show how 
positive affect in children is associated with internalizing problems (Wang & Saudino, 2015).  
Personality traits are important in the study of symptoms of depression as a risk factor of MI, 
as personality is linked to psychopathology (Ormel et al., 2013) as well as treatment-outcome 
(Takahashi et al., 2013). 
Personality, depression and coronary heart disease 
Several researchers have advocated the importance of focusing on specific aspects of 
depression and anxiety to understand their contribution to the development of CVD (Baune et 
al., 2012; Batelaan, 2014; Hawkins et al., 2013, Shaffer; et al., 2012).  However, positive and 
negative affect as specific aspects of specific types of anxiety and depression are closely 
linked to more dispositional tendencies in emotions (Clark, 2005; Watson & Naragon-Gainey, 
2014). The acknowledgement of more general dispositions has a long history, but the 
inconsistency in research on both anxiety and depression as risk factors of Myocardial 
Infarction (MI) has caused researchers to take a second look at broader dimensions of 
dispositional affect as a psychological risk factor of CHD (Suls & Bunde, 2005; Edmondson 
et al., 2013; Jokela, Pulkki-Råback, Elovanio, & Kivimäki, 2013; Roest et al., 2010). 
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The dominant model within trait theory is the five factor model of personality (McCrae & 
John, 1992; McCrae & Costa, 2008; McCrae, 2010). In this model, five broad dispositions, 
neuroticism, extroversion, openness to experience, agreeableness and conscientiousness, 
reflect basic tendencies in feeling, thinking and acting in certain ways. Personality traits 
influence both frequency and intensity of positive and negative emotions (Ching et al., 2014). 
While the trait approach describes dimensional aspects of personality, the typology approach 
focuses on the distribution of individuals into distinct categories. In the 1950s, the Type A 
personality was introduced as typology characterized by aggressiveness, impatience, 
excessive competitiveness and time urgency (Friedmann & Rosenman, 1959). Although 50 
years of research has failed to support Type A personality as a risk factor of CVD, it 
continues to linger in the research field as well as in the public opinion. A recent large-scale 
study applying different measures of Type A assessment concluded that there is no evidence 
to support the Type A as a CVD risk factor (Smigelskas, Zemaitiene, Julkunen, & Kauhanen, 
2015).  Hostility has received somewhat more elevated status in the research field and has 
also been found to be a precursor to the development of depression (Stewart, Fitzgerald, 
Kamarck, 2010). Further, a promising replacement of the Type A personality was made by the 
introduction of the type D personality, a composite of two sub-factors, i.e. social inhibition 
and negative affect (Denollet, 2000). A review of the prognostic value of Type D in cardiac 
samples concludes that the effect sizes have probably been overestimated (Grande, Romppel, 
& Barth, 2012). As an etiologic factor, Type D has received less attention, but in a recent 
study, the Type D personality construct failed to be successfully associated with incident 
CHD (Larson, Barger & Sydeman 2013). However, the sub-component of Type D, namely 
social inhibition, along with anger-personality has been associated with coronary artery 
plaque in CHD-free populations (Compare, et al. 2014). The Type D personality is related to 
the personality traits in the five factor model, where social inhibition shows a strong negative 
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relationship to extroversion, and a more moderate positive relationship to neuroticism (De 
Fruyt & Denollet, 2002). In a recent analysis of three cohort studies, neuroticism was 
associated with cardiovascular diseases, especially CHD (Jokela et al., 2013). However, Lee 
and colleagues (2014) found that low extroversion was more important than high neuroticism 
in constituting a risk of incident CHD.  A meta-analysis by Richardson and colleagues (2012) 
has concluded that perceived stress is associated with increased risk of incident CHD. Given 
the strong link between personality and stress-processes (Ferguson, 2013; Friedman & Kern, 
2014; Hervas & Vazquesz, 2011), stable dispositions should be given more attention in the 
study of the etiology of CHD. This is further supported by recent research in 
psychophysiology concluding that cardiovascular responses to psychological stress represent 
stable individual traits (Dragomir, Gentile, Nolan, & D`antono, 2014).  
Personality traits are associated with acute major depression across the age spectrum (Weber 
et al., 2012). Different models have been proposed to explain the relationship between 
personality traits and psychopathology, but can, according to Klein and colleagues (2011), be 
divided into three groups, where the first group views personality and depression as having 
similar causal influences, although they do not causally influence each other. In the second 
group, consisting of what is referred to as the predisposition and pathoplasticity model, 
personality has a causal effect on the onset, or the maintenance of depression in terms of 
vulnerability and predispositions (etiopathogenesis). In the third group, 
(concomitants/consequence), depression is suggested to have a causal influence on 
personality, and is also referred to as the “scar” hypothesis, in which depression causes 
personality alteration (Ormel et al., 2013).  Neuroticism has received substantial attention in 
the study of depression as vulnerability-factor, sharing the same genetic background (Ormel et 
al., 2013; Clark, 2005).  Shared genetic contribution is still under investigation, and Hirvonen 
and colleagues (2015) have found that neuroticism is correlated to serotonin receptor binding 
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in healthy individuals. Extroversion has received less attention, but more recently, a focus on 
different aspects of extroversion and psychopathology has emerged (Watson et al., 2015).  
Ormel and colleagues (2013) has reviewed the evidence for the different models and 
concluded that none of the models can fully explain the relationship observed between 
neuroticism and common mental disorders like anxiety and depression, although the common 
cause model and vulnerable-model have received the most empirical support, whereas the 
opposite is the case for the scar-model.  
The five-factor model has received exhaustive support (McCrae, 2010). However, recent 
physiological approaches to personality have also focused on a more general meta-trait, where 
negative and positive affect represent basic overarching dispositions referred to as stability 
and plasticity, respectively (DeYoung, 2010). Stability is closely related to neuroticism and 
serotonin, while extroversion represents the plasticity meta-trait and is related to 
dopaminergic activity (DeYoung, 2010). Another physiological approach to personality is the 
Behavioral Activation System (BAS) and Behavioral Inhibition System (BIS) that represent 
two general motivational systems that underlie behavior and affect (Gray, 1981) as well as 
responses to reward and punishment (Carver & White, 1994). BIS/BAS has also been 
suggested as a theoretical model that can explain the comorbidity of anxiety and depression as 
BIS-sensitivity is associated with both anxiety and depression, whereas low BAS-sensitivity 
is specific to depression with anhedonic symptoms (Cummings et al., 2013, p. 822).   
Neuroticism is strongly correlated with symptoms of depression and anxiety (Ormel et al., 
2013; Jylhä & Isometsä, 2006), and large meta-analysis confirms the strong association 
between neuroticism, distress, and anxiety disorders (Kotov, Gamez, Schmidt, & Watson, 
2010). Extraversion on the other hand is negatively associated with depression (Jylhä & 
Isometsä, 2006) and mental disorders (Kotov et al., 2010: Watson & Naragon-Gainey, 2014). 
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In addition, a recent study by Watson and colleagues (2015) has investigated the relationship 
between extroversion and psychopathology on the facet level, and found that positive 
emotionality, a facet representing extroversion, is especially strongly linked to depressive 
symptoms and diagnosis. Gender differences in personality are small but consistent across 
cultures (Costa, Terracciano, and McCrae, 2002); women tend to score higher on neuroticism 
compared to men. Given the gender differences in psychological variables like depression, 
anxiety and personality traits, focusing on gender-specific psychological risk factors of MI is 
warranted.  
Women and coronary heart disease  
According to Wenger (2012), women have been “understudied, underdiagnosed and 
undertreated” (p. 604) in cardiac research. Women have been marginalized in the research 
field in general (Orth-Gomer, Schneiderman, Vaccarino & Deter, 2015), and studies focusing 
on psychological risk profiles in particular have been lacking (Naqvi, Naqvi, & Merz, 2005). 
In women, symptoms of Myocardial Infarction are more atypical, as they are less likely than 
men to experience chest pain before an MI compared to men; however, they are significantly 
more likely to experience dizziness, fatigue, and pain located in the neck, jaw and right-arm 
(Coventry, Finn, & Bremner, 2011). Although several risk-factors are common, some, like 
hormone therapy, oral contraceptives, menopause, preeclampsia, and polycystic ovary 
syndrome, are unique for women (for an overview, see Tan, Gast, & van der Schouw 2010). 
Although unquestionably important, the scope of this thesis is not risk factors unique for 
women, but rather psychological variables that are common in men and women, constituting 
differentiated risk-estimates. The impact of non-traditional risk factors of CHD in women is 
of special interest given the increased prevalence of psychological risk factors like anxiety 
and depression among women (Metha, Wei, Wenger, 2015). Furthermore, because cardiac 
events are more likely to occur asymptomatically (i.e. without experiencing symptoms), the 
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focus on risk factors is even more crucial for women.  Traditional risk-factors like being 
overweight, smoking and diabetes, as well as psychological factors, show differential risk 
impact on men and women (Lloyd et al., 1996; Tan et al., 2009). Although the biological 
aspect, including how sex hormones affect neurotransmitters like serotonin and dopamine 
(Barth, Villringer, & Sacher, 2015), are important, social variables are also relevant. Möller-
Leimkühler (2007) points to studies showing that women in high control-high demand jobs, in 
typically male-dominated occupations, and combined work-family demands, are at a higher 
risk of having an MI.  An interaction between neuroticism and socio-economic status (SES) 
has been observed as a gender specific risk factor of cardiac mortality (Hagger-Johnsen et al., 
2012). In the study by Hagger-Johnsen and colleagues (2012), women with low SES and high 
neuroticism were at a higher risk of cardiac mortality, whereas for those with high SES, high 
neuroticism predicted a reduced risk of mortality. This pattern was not observed in men. In 
addition, women tend to report more stress and symptoms of exhaustion than men, and more 
work-family demand (Wiegner, Hange, Björkelund & Ahlborg, 2015), emphasizing the role 
of the social context. 
Although most of the literature concerning symptoms of depression as risk factors of CVD 
has not performed separate analysis for men and women, there are some exceptions. In a 
Finnish study, symptoms of depression predicted all-cause mortality in both genders, but 
CVD events only in women (Haukkala, Konttinen, Uutela, Kawachi, & Laatikainen, 2009). In 
another study, depressive symptoms were an independent risk factor for CHD in women but 
not in men (Mendes de Leon et al., 1998). However, in a French population-based study, 
depressive mood predicted cardiovascular mortality only for men (Lemogne et al., 2012). 
These findings emphasize the importance of both screening for depression in general and the 
particular focus on the gender-specific role of depression in preventive heart intervention. 
Changing practices by healthcare providers designed to reverse the trend of late referral and 
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late intervention may substantially reduce the number of women disabled and killed by CHD 
each year (Wenger, 2003). According to the European guidelines on cardiovascular disease 
prevention in clinical practice (Perk et al., 2012), it is crucial to include psychosocial factors 
in the risk assessment of CHD, but no gender-specific risk factor regarding anxiety and 
depression is presented, and the guidelines lack specification regarding types of screening or 
instruments to apply.  
Several reviews on the relationship between depression and CHD (e.g. Wulsin & Singal, 
2003; Nicholson, Kuper, & Hemingway, 2006; Van der Koy, Hout, Marwijk, Marten, 
Stehouer, & Beekman, 2007; Stampfer et al., 2012) and prospective studies (e.g. Hawkins et 
al., 2013; Gustad et al., 2013) strongly support that there is an association between depression 
and CHD. However, separate analyses for men and women are lacking. Among women, there 
has been an increased prevalence of coronary heart disease, and the role of depression as a 
gender-specific factor is unclear (Naqvi et al., 2005). Women with depressive symptoms have 
been found to have higher CRP levels (a risk factor of the development of CHD) compared to 
men with depressive symptoms, suggesting the importance of giving clinical attention to 
women with high cardiac risk when they experience depressive mood (Azar, Nolan & 
Stewart, 2011).  
Gender differences in anxiety and depression 
Prevalence, incidence, and morbidity risk of depressive disorders are higher in females than in 
males (Piccinelli & Wilkinson, 2000). The lifetime prevalence of affective disorders among 
women is almost doubled compared to men (Faravelli et al., 2013), and for major depression, 
the prevalence ratio is even worse for women (Delisle, Beck, Dobson, Dozois, & Thombs, 
2012). Considerable cross-country differences exist, and compared to other European 
countries, the level of depressive symptoms is lowest in Norway (Van de Velde, Bracke & 
Levecque, 2010).  
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Gender differences vary across sub-groups of depression (Baune, Adrian, Arolt & Berger, 
2006). Different measures of depression tend to display differentiated gender differences 
(Salokangas, Vaahtera, Pacriev, Sohlman, & Lehtinen, 2002), and in some self-report 
instruments, the differences are reversed, i.e., men have a higher score on depression (Stordal, 
Kruger, Dahl, Kruger, Mykletun, & Dahl, 2001; Nortvedt, Riise, & Sanne, 2006). At the 
symptom level, different gender subtypes can be identified (Alexandrino-Silva, Wang, Viana, 
Bulhoes, Martins, & Andrade, 2013), and this might have implications for understanding the 
depression–CHD relationship. Dysthymia, characterized by chronic lack of enjoyment, 
depressive mood, loss of interest and drive, with a long duration (at least two years), with 
depression symptoms milder than major depression, presents gender differences of a smaller 
magnitude than unipolar major depression (Baune et al., 2006). Gender differences in the 
tendency to report somatic symptoms has been suggested as an explanation of gender 
differences in depression, but have recently been found to be of less importance (Delisle et al., 
2012). Scales that measure anhedonia do not present gender differences in the general 
population or patient groups (Snaith, Hamilton, Morley, Humayan, Hargreaves & Trigwell, 
1995; Nakonezny et al., 2010), suggesting that lack of expected gender differences in HADS-
D might be due to the anhedonic content in the scale. A large-scale systematic review of 
depression in MI patients by Doyle and colleagues (2015) showed that women were more 
depressed than men, but the prognostic value of depression was more important for men than 
women, addressing the importance of treating women and men as different populations in 
cardiac research on psychological risk factors.  
Gender differences in depression differ from gender differences in CHD, suggesting that the 
association between depression and CHD is gender specific (Low, Thurston, & Matthews, 
2010). This discrepancy might be explained by the reduction in the risk of affective disorder 
for women after menopause (Faravelli et al., 2013). However, more research is needed on the 
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gender-specific link between depression and CVD (Orth-Gomer & Deter, 2015). Gender 
differences might be linked to treatments of depression and their effectiveness in men and 
women (Naqvi et al., 2005), and depression might systematically vary with other risk factors 
in different ways in men and women. In recent years, waist-hip ratio (WHR) has emerged as a 
superior predictor of CVD compared to, for example, body mass index (BMI) (de Koning, 
Merchant, Pogue, & Anand, 2007), and WHR seems to be a stronger predictor in women 
compared to men (Möller-Leimkühler, 2007), although others find a similar strength of 
association in men and women (de Koning et al., 2007). It has been pointed out that women 
and men with CHD represent different populations, and that the practice of using men as 
references should be reconsidered (Wenger, Shaw, & Vaccarino, 2008).  
 
Aims and objectives 
To understand the role of symptoms of anxiety and depression in predicting Myocardial 
Infarction (MI) in the general population, we need to (1) identify symptoms of depression and 
anxiety as causes of MI, not only consequences of MI. Further, (2) it is important to identify 
gender-specific psychological risk-profiles in order to optimize the screening of MI-risk. To 
identify the optimal screening tool and understand the relationship between psychological 
symptoms and MI, (3) there is a need to focus on the content in the specific instrument used, 
and how specific symptoms are related to more general emotional dispositions.   
Paper I  
The aim of paper I was to identify a dose-response relationship between symptoms of anxiety 
and depression, and the risk of incident MI. Further, to compare the role of anxiety and 
depression as both predictor of, and outcome after MI. This was done by combining the 
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etiological approach with the prognostic approach, focusing on symptoms of anxiety and 
depression before and after incident MI.  More specifically, the following research questions 
were formulated: 
1. Do elevated symptoms of depression in a population free of CHD at baseline increase 
the risk of incident MI?  
2. How are levels of anxiety and depression affected by having an MI?  
3. Is the level of anxiety and depression in patients with a history of MI affected by time 
since the MI? 
 
Paper II 
The aim of paper II was to identify a gender-specific psychological risk estimate of having a 
fatal or non-fatal MI. The objective was to investigate whether elevated symptoms of 
depression or history of depression provide the best risk estimate for men or women, 
respectively. In addition, to follow up on the findings in Paper I, the possibility of elevated 
levels of anxiety-symptoms measured by HADS as a cardioprotective factor was investigated.  
1. Are there gender differences in incident MI risk-estimate based on the HADS-
depression scale?  
2. Does history of depression offer a more efficient tool for detecting MI risk than 
HADS? 
3. Do elevated symptoms of anxiety measured by HADS represent a reduced risk of 
having an MI among both men and women free of CHD at baseline?  
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Paper III 
To identify the optimal screening tool and understand the relationship between psychological 
symptoms and MI, there is a need to focus on the content in the specific instrument used, and 
how specific symptoms are related to more general emotional dispositions. The aim of paper 
III was to investigate the validity of HADS as a measure of anhedonic depression.  To explore 
the relationship between HADS-A and HADS-D and trait and state positive affect to 
understand the content in the scales, gender differences were of special interest. The research 
questions outlined included: 
1. How are the anxiety and depression scales in HADS related to negative and positive 
affect? 
2. Can the personality traits neuroticism and extraversion predict symptoms of anxiety 
and depression measured by HADS?  
3. Can anhedonia explain contradictory gender differences observed in HADS-D? 
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Method 
The papers in this thesis are based on two sources of data. Paper I and II utilize longitudinal 
data collected through the HUNT study (HUNT 2 and 3). The sample in paper III consists of 
psychology students enrolled at The Norwegian University of Science and Technology 
(NTNU). The instruments and measurement procedures will be described in the next section, 
followed by a presentation of the different analyses applied.  
Instruments 
This study made use of self-report of psychological variables, self-report and clinical 
assessment of health-variables. To identify cases of incident Myocardial Infarction, self-report 
and register-data by linkage to the mortality-register were used.  
 
Self-reported measures 
Diabetes 
In HUNT 2, the participants were asked to answer the question “Do you have diabetes?” by 
checking “yes” or “no.” 
Smoking  
Smoking was self-reported and operationalized as numbers of years of daily smoking.   
HADS 
The Hospital Anxiety and Depression Scale. The Hospital Anxiety and Depression Scale 
(Zigmond & Snaith, 1983) includes 14 items that indicate the way the respondent has felt over 
a two-week period prior to measurement (Table 1.). The HADS usually operationalize anxiety 
and depression by cut-off scores ( 8), but in papers I and III, the computed indexes were 
treated as continuous variables.   
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Table 1. Item order and label in the Hospital Anxiety and Depression Scale   
  
Item number Item text Scale content 
 1 I feel tense or wound up Anxiety 
2 I still enjoy the things I used to enjoy Depression 
3 I get a sort of frightened feeling as if  
something awful is about to happen 
Anxiety 
4 I can laugh and see the funny side of things Depression 
5 Worrying thoughts go through my mind Anxiety 
6 I feel cheerful Depression 
7 I can sit at ease and feel relaxed Anxiety 
8 I feel as if I’m slowed down Depression 
9 I get a sort of frightened feeling like ‘butterflies’ 
 in the stomach 
Anxiety 
10 I have lost interest in my appearance Depression 
11 I feel restless as if I have to be on the move Anxiety 
12 I look forward with enjoyment to things Depression 
13 I get sudden feelings of panic Anxiety 
14 I can enjoy a good book or radio or TV show Depression 
 
 
History of depression/major depressive episode  
In an extended part of the HUNT 2, the participants were instructed to indicate whether, 
during their life, there had been periods of two consecutive weeks or more when they “felt 
depressed, sad, and down,” “had appetite problems or ate too little,” “felt weak (adynamic) or 
lacked energy,” “really reproached yourself and felt worthless,” or “had problems 
concentrating or had difficulty making decisions.” Participants were classified as having 
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experienced a depressive episode if they answered yes to the question, “During your life, have 
there been periods of two consecutive weeks or more when you had at least three of the 
above-mentioned problems simultaneously?”  
PANAS 
The Positive and Negative Affect Schedule (PANAS) consists of two 10-item mood scales 
that measure the two dominant affect structures, and were developed by Watson, Clark and 
Tellegen (1998). PANAS offers a variety of instructions depending on the concept of interest; 
i.e. trait or state positive and negative affect. In this current study, the respondents were 
instructed to report how they have felt over a two-week period prior to measurement. PANAS 
has shown very good psychometric properties in the general population, with a high internal 
consistency and construct validity (Crawford & Henry, 1999).  
 
NEO FFI: Extroversion and neuroticism  
Costa and McCrae developed the NEO Personality Inventory Revised (NEO PI R) to 
operationalize the five factor model of personality traits. The short form, the NEO Five-factor 
Inventory (NEO FFI), consists of 60 items representing the domains Neuroticism, 
Extroversion, Agreeableness, Openness to Experience, and Conscientiousness. In this study, 
the Extroversion and Neuroticism domain were operationalized by 24 items with a five-point 
Likert scale ranging from 1 (“strongly disagree”) to 5 (“strongly agree”). The psychometric 
properties of NEO FFI are well documented (Costa & McCrae, 1992; Martinsen, Nordvik, & 
Østbø, 2011).  
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Clinical measures 
Cholesterol  
Total serum cholesterol was measured applying an enzymatic colorimetric cholesterol 
esterase method (Holmen et al., 2003). 
Blood pressure 
At HUNT 2, the participants’ systolic blood pressure (SBP) was measured by specifically 
trained nurses, using a cuff adjusted for arm circumference. SBP was measured three times, 
and a mean was calculated from the second and third observations to ensure reliable 
measurements.  
Waist circumference and Waist/hip ratio 
Waist and hip circumferences were measured with a steel band to the nearest 1.0 cm with the 
participant standing and with the arms hanging relaxed. The waist circumference was 
measured horizontally at the height of the umbilicus, and the hip circumference was measured 
at the thickest part of the hip (Holmen et al., 2003).  
In Paper II, the waist/hip ratio (WHR) was applied instead of waist circumference, i.e., the hip 
circumference was divided on the waist circumference to calculate the ratio.  Cut-off scores 
were calculated based on The International Diabetes Federation (IDF).  WHR was used 
instead of WC in Paper II as they provide recommendations that are gender, population, and 
geography specific. For Europeans, the recommended cutoff scores are .80 for women and .94 
for men to identify central obesity (Alberti, Zimmet & Shaw, 2006). 
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Register data 
Fatal MI  
The mortality data were obtained from the National Mortality Register by combining the 
mortality database and the HUNT data by means of an 11-digit personal identity number. In 
the mortality registry, diagnoses are encoded according to International Classification of 
Diseases, 10th Revision (ICD-10). MI mortality in this study encompasses ICD-10 codes I21-
9, unspecified acute MI, and I22-9 subsequent MI (within four weeks of a preceding MI) with 
an unspecified location, with the majority of cases being I21-9. Non-fatal MI was indicated by 
self-report in the HUNT 3 study as a “yes” or “no” response to the question, “Have you ever 
had or do you have Myocardial Infarction?”  
 
The HUNT Study 
The Nord-Trøndelag Health Study (The HUNT Study) is a collaboration between HUNT 
Research Centre (Faculty of Medicine, Norwegian University of Science and Technology 
NTNU), Nord-Trøndelag County Council, Central Norway Health Authority, and the 
Norwegian Institute of Public Health. HUNT is one of the largest health studies ever 
performed and is thoroughly described by Holmen and colleagues (2003). It is a unique 
database of personal and family medical histories collected during three intensive studies. 
HUNT 1 was carried out in 1984-1986 to establish the health history of 75,000 people. The 
succeeding HUNT 2 was carried out in 1995-1997 and focused on the evolution of the health 
history of 65,049 people. HUNT 3 was completed in June 2008 and 48,289 people 
participated (52% participation rate). The data was collected by means of questionnaires, 
interviews, clinical examinations and the collection of blood and urine samples. 
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Sample and procedure  
Paper I   
In Paper I, participants free of CHD at baseline (HUNT 2) were included in the study. History 
of MI and past or present angina was applied as exclusion criteria, leaving us with 62,919 
eligible candidates of whom 28,859 also participated in HUNT 3. Within this group, 770 
participants reported a current or prior incident of non-fatal MI during the follow-up period. 
Men were overrepresented in the MI-group where only 32.21 percent were women. The mean 
age was 46.97 (13.04). 
Paper 2  
As in Paper I, participants free of CHD at baseline (HUNT 2) were included in the study. 
History of MI and past or present angina was applied as exclusion criteria. The inclusion 
criteria in Sample II also included a response to “history of depressive episode.” The mean 
age of women was 43.12 (13.07) and men 43.61 (12.90). Of the 41.248 participants meeting 
the inclusion criteria, 242 women and 580 men had an MI (fatal or non-fatal). In all 41.7 
percent of the fatal/non-fatal MI group was women. A total of 23066 of the participants in 
Sample II also constitute a substantial part of Sample I (28,859). Differences in sample sizes 
are due to different inclusion criteria (e.g. valid HADS-score at HUNT 3 in Sample I) and the 
use of mortality register in Sample II.  
Paper III  
HADS were administered along with FFI, and PANAS to a Norwegian sample of 
undergraduate students (N = 350) at the department of psychology; NTNU. The instruments 
were distributed through an open link on the intranet Web page. Eight weeks later, a new link 
was posted on the Web site. Because of theoretical relevance and drop-out concerns, only the 
“big two” of the five factors in the FFM, i.e. Extroversion and Neuroticism, were included.  
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The participants were instructed to create a personal code that should be used to match the 
participant’s responses from the two surveys. In all, the 160 participants in Sample II were 
identified with responses in both surveys. Women were overrepresented in both sample one 
and two; 75.5 and 70.0 percent, respectively. The time span between the two points of 
measurement ranged from 35 to 66 days, with a mean of 50.95 (SD=6.65) days. The mean age 
was 22.13 (SD = 4.30) and in the follow-up sample, the mean age was 22.18 years (SD = 
4.45). 
Analysis  
Analysis of dropouts and missing data 
In the HUNT study, a thorough investigation of completers versus drop-outs has been 
performed. According to Langhammer and colleagues (2012), participation in HUNT 2 and 
HUNT 3 is associated with better mental and physical health. Participation depended on age, 
sex and type of symptoms and diseases. Among non-participants, the prevalence of 
cardiovascular diseases, diabetes and psychiatric disorders were higher, based on data 
extracted from general practice.  Furthermore, registry data showed that the non-participants 
had lower socioeconomic status and a higher mortality than the participants (Langhammer et 
al., 2012).  
Logistic regression 
The goal of paper I and II was to investigate differences in risk, and the results from a logistic 
regression analysis were regarded as the best way to produce easily, interpretable estimate. 
Logistic regression is a robust analysis that served this purpose very well.  It is not the time 
that is the main interest in this study, and in an analysis in which outcome is simply treated as 
binary, logistic regression is informative and easily interpretable. Furthermore, in the self-
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reported MI-group (HUNT 3), the time of MI was not reported in several cases. In this 
situation, it is advantageous to treat the outcome variable as binary. 
Hierarchical, block-wise regression 
Hierarchical block-wise hierarchical linear regression was used in papers I and III. Before 
running the analysis, the data was pre-analyzed to ensure none of the assumptions were 
violated.  All indicators were within the established criteria (e.g. VIF <10).   
Test of bivariate association and group differences 
In all three papers, t-test and chi-square test were used to test the significance of group 
differences and association between categorical variables.  
Significance testing of differences in risk estimate 
Post-hoc analysis applying the formula suggested by Paternoster, Brame, Mazerolle, and 
Piquero, (1998) were used to test the significance of the differences in risk estimate in Paper 
II.  
Ethical considerations 
The Regional Committee for Ethics in Medical Research has considered and approved this 
research project (reference in REK: 2010/393). The protocols for HUNT 2 and HUNT 3 were 
approved prior to this specific study. A specific request for approval was made for the linkage 
to the mortality register applied in Paper II. All participants in the HUNT 2 and HUNT 3 
study gave their written consent. In Sample III, informed consent was assured by informing 
the student that participation was absolutely voluntary and that they were able to withdraw 
from the study at any time, without any questions being asked.  As Sample III consists of 
responses made to an anonymous online survey, the protection of the participants was 
considered to be within standards.   
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Results  
Paper I. Symptoms of depression and anxiety before and after myocardial 
infarction: The HUNT 2 and HUNT 3 study 
In Paper I, a request in the research field to treat depression as a continuous variable was met.  
Further, few, if any, had measured symptoms of anxiety and depression before and after an 
MI. Although a few studies had asked MI patients about past history of depression, the 
general view in the prognostic approach was that symptoms of depression, mainly, and to a 
lesser extent, anxiety, were directly attributed to the experience of having a heart attack. In 
this study, 28,859 participants with no prior CHD (MI or Angina) and with a valid score on 
HADS in HUNT 2 and HUNT 3 participated. Of those, 770 reported that they had a 
Myocardial Infarction during the five to eight years’ time-span between HUNT 2 and HUNT 
3. The results demonstrated a dose-response positive relationship between symptoms of 
depression and the risk of having an MI, where a one unit increase in symptoms of depression 
increased the risk of having an MI (OR 1.01) more than one year of daily smoking, one unit 
increase in systolic blood-pressure (e.g. 122 to 123) or one cm wider waist-circumference. 
Anxiety, on the other hand, was negatively associated with MI risk, although the risk estimate 
(OR .96) was not significant. The symptom-level of anxiety at baseline was significantly 
lower in the MI-group compared to the non-MI group, warranting further investigation of the 
role of anxiety. The long-term stability coefficient observed between HADS-scores at HUNT 
2 and HUNT 3 suggested that symptoms of anxiety (r .57) and depression (r .54) measured by 
HADS represent more stable dispositions. Regression analysis showed that a substantial part 
of the variation in HADS-A and HADS-D scores at HUNT 3 could be predicted by baseline 
symptom levels at HUNT 2 (R² =.34 and .30, respectively). In the total sample, MI only 
marginally predicted the symptom-level of depression (ȕ .01, p <. 05). In the MI-group, the 
time since MI was not a significant predictor of level of anxiety and depression. In sum, the 
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results suggest that symptoms of depression measured by HADS are important in the etiology 
of MI, and that symptoms of depression among MI patients might represent a more general 
and stable disposition that is best considered as the cause of MI rather than the consequence. 
Furthermore, symptoms of anxiety presented a reversed relationship to MI and should be 
subject to further inquiry.  
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Paper II. Anhedonic depression, history of depression, and anxiety as 
gender-specific risk factors of myocardial infarction in healthy men and 
women: The Hunt study 
In Paper II, the search for a gender-specific relationship between different measures of 
depression and MI identified that HADS-D was significantly better at identifying women at 
risk of MI than men. Significantly more women had a history of depression (ĭ .16, p <.001) 
and elevated symptoms of anxiety (ĭ .07, p < .001). More men had elevated symptoms of 
depression (HADS-D  8); however, although significant the difference was marginal. 
Women with a  HADS-D score of or above 8 were more than twice as likely to have an 
fatal/non-fatal MI, even after controlling for traditional factors, symptoms of anxiety and 
history of depression (OR=2.31). HADS-D was not a significant predictor of MI among men 
in the adjusted model. Symptoms of anxiety as a cardioprotective factor were supported, as 
elevated symptoms of anxiety (HADS-A  8) significantly reduced the risk of having an MI 
in both men (OR = .65) and women, (OR = .55) although the effect-size was somewhat 
stronger for men. In the total sample, a history of depressive episode was a significant 
predictor of MI in the adjusted model (OR = 1.29). Gender-specific analysis showed that a 
depressive episode was a significant predictor among men (OR = 1.44) but not women.  The 
results confirmed that gender differences in risk estimate are important. Depression measured 
by HADS presented rather contradictory results considering the literature on gender 
differences in depression. Depression measured by HADS has a specific focus on anhedonia; 
a symptom aspect that might be more cardio-toxic than other symptom-clusters, especially for 
women. To summarize the findings, there is a need to treat men and women as separate 
populations in the research on depression as an etiological factor of depression. HADS-D is 
suggested as a simple and effective tool for identifying women at risk of having an MI. 
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Psychological tools for screening should be gender-specific, and the role of anxiety as a risk 
factor in the development of MI should be reconsidered or perhaps reversed.      
 
47 
 
 
Paper III: Personality traits, gender differences and symptoms of 
anhedonia: What does the Hospital Anxiety and Depression Scale (HADS) 
measure in nonclinical settings?  
In Paper III, the aim was to understand why HADS-D predicts MI in patients free of CHD at 
baseline whereas an opposite trend is observed for HADS-A. In Papers I and II, the anhedonic 
content in the depression scale is suggested as a reason for its superiority in detecting those at 
risk, but the literature relating HADS to measures of positive affect is scarce. The results from 
Paper I suggested that the dimensions in HADS represent more stable dispositions; Paper II 
suggested that gender differences in HADS was in need of further investigation.  In this study, 
the results showed that HADS-A was strongly linked to both state and trait negative affect, 
and that neuroticism measured at T1 predicted a substantial part of the variance in HADS-A at 
time 2 (R² =.44). Neuroticism and extroversion predicted HADS-D at T2 (R² =.35). The 
results were congruent with the tripartite model of anxiety and depression. The results 
indicated that positive affect differentiated the anxiety and depression scale in HADS, but also 
that HADS-D is only relatively moderately associated with negative affect. Gender 
differences were as hypothesized; women had a significantly higher score on all instruments 
measuring negative affect (PANAS-Negative affect, Neuroticism, HADS-A), but a lower 
score on HADS-D. No significant gender differences were observed on extroversion and 
PANAS-positive affect. The anhedonic content in the HADS-D scale was suggested as an 
explanation of the reversed gender differences in depression observed when HADS is used in 
non-clinical samples.  
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Discussion 
Personality traits represent a stable tendency in the experience of positive and negative affect. 
These differences are expected to persist through life, and beyond major life events like 
having a heart attack. The prognostic approach to depression in CHD/CVD patients seems to 
have overlooked contributions from the etiological approach. Depression as a risk factor of 
mortality in CHD/CVD patients should incorporate the role of depression as a general risk 
factor of mortality, as the risk estimates of all-cause mortality are stronger than those 
observed for cardiovascular events in MI patients (Doyle et al., 2015). In Paper I, elevated 
symptoms of depression constituted an independent risk of having an MI, even when 
controlling for the major risk factors and symptoms of anxiety. Although the American Heart 
Association has recommended screening for depression in cardiac patients, others are critical, 
as the benefits in terms of reduced symptoms or improved prognoses has received marginal 
support (Thombs et al., 2013; Vieweg et al., 2011). Among the participants, having an MI did 
not affect the level of symptoms of anxiety and depression, a finding consistent with other 
studies on the long-term psychological effect of MI (e.g. Hanssen et al., 2009), but at the same 
time contradicts others (e.g. Doyle et al., 2015). Furthermore, time since MI was not a 
predictor of symptom-level anxiety and depression in the MI-group, a finding that 
strengthened the role of depression as a risk factor more than being a prognostic factor caused 
by having an MI. It might be that screening for depression to identify the risk of MI would be 
a better way of using resources.  
While Paper I confirmed the symptoms of anhedonic depression predicting MI, Paper II 
compared HADS-D to other measures of depression as potential tools for detecting those at 
risk of incident MI.  Paper II followed up on the results from Paper I, where symptoms of 
anxiety at baseline were significantly lower in the MI group compared to those that suffered 
from a heart attack in the succeeding years. Gender-differences in risk estimate based on 
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HADS-D further called for the understanding of gender differences in HADS and how 
personality traits and individual differences in experiencing positive and negative affect could 
account for them, as the level of symptoms of anxiety and depression measured for five to 
eight years had a substantial impact on the current level of symptoms of anxiety and 
depression in both the MI and non-MI group (Paper I). Several researchers in the field of 
cardiac research have addressed the need to focus on how depression and anxiety are 
operationalized in order to understand their role as risk factors of MI (e.g. Davidson, 2008; 
Davidson, Rieckmann, & Rapp, 2005; Schaffer et al., 2012; Baune et al., 2012). 
Inconsistences in the measurement of depression and anxiety are not only important for 
understanding the link between psychological variables and CVD, but for the diagnosis and 
treatment of depression in general (Fried & Nesse, 2015). Together, the results from this study 
suggest that HADS-D represents a specific, anhedonic subtype of depression, closely linked 
to dispositional tendencies in experiencing positive affect.  
Anxiety as a cardioprotective factor? 
In Paper I, the level of symptoms of anxiety was significantly higher in the MI group 
compared to the non-MI group. Anxiety was associated with a lower risk of having a non-
fatal MI, but the risk estimate (OR) was not significant when controlling for the established 
risk factors (i.e. smoking, age, gender, hypertension, central adiposity, and diabetes). In Paper 
II, anxiety was operationalized by the cut-off score; a stronger manipulation of the variable 
and predicted reduced risk of fatal/non-fatal MI.  Others (e.g. Janszky et al., 2010) have found 
that anxiety is an independent risk of CVD/CHD; therefore, the findings from this study 
should be treated with caution. It is also important to consider a potential curve-linear effect 
between symptoms of anxiety and the risk of MI. However, Meyer and colleagues (2015) 
found in a sample of stable CHD-patients that the highest quartile of HADS-A (10) was 
most strongly associated with reduced mortality. Although this study does not rule out the 
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possibility of a positive relationship between specific subtypes of anxiety (e.g. panic disorder 
or social phobia) and specific CVD outcome, the results from this current study strongly 
suggest that an elevated score on HADS-A does not constitute an elevated risk of having an 
MI in the general population. On a more general, theoretical level, anxiety can be both 
adaptive and maladaptive (Nesse, 1999). Anxiety and depression have been found to have an 
inverse association with health behavior in MI patients (Benyamini et al., 2013), and although 
not directly transferable to healthy populations, it might be that those reporting more anxiety 
have a higher risk-perception and hence live a more healthy life, attending to symptoms.  
However, anxiety as a health-promoting factor has received marginal support (Tully et al., 
2011); and perhaps the most plausible explanation for inconsistent findings of anxiety as a 
risk factor of MI is heterogeneity in measurement of anxiety and heterogeneity in outcome 
variable. Further, Cohen and colleagues (2015) argue that some anxiety scales assess somatic 
symptoms (e.g. irregular heartbeat and chest pain) which may be symptoms of cardiovascular 
abnormalities rather than symptoms of anxiety (p. 4). As HADS do not contain somatic 
symptoms, this could be a possible explanation of inconsistencies, and why HADS-A did not 
predict MI in this study. As noted by Baatelan and colleagues (2014), different anxiety 
disorders have differential impacts on the onset of cardiovascular disease. Panic disorder, with 
symptoms that mimic those of acute heart failure, predicts the onset of CHD events (Walters 
et al., 2008). However, as the etiology is still controversial, Tully and colleagues (2015) have 
outlined a systematic review to further investigate the link between panic disorder and 
incident CHD. The results from this review can probably inform and guide future research on 
the subject.   
Comparing different Axis I lifetime diagnosis, neither panic disorder, generalized anxiety 
disorders, obsessive-compulsive disorder (OCD) nor social phobia were significant predictors 
of CHD whereas depression was (Lee et al., 2014).  Both GAD and OCD were associated 
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with lower risk (not significant) while social phobia and panic was, although not statistically 
significant, associated with higher risk of CHD. A framework for differentiating the specific 
anxiety disorders, and moreover, symptoms of anxiety and depression, is by focusing on their 
relation to personality. Neuroticism is strongly related to all internalization-disorders and 
symptoms of anxiety and depression, while extroversion, on the other hand, is specifically 
related to depression, but also to social phobia (Watson et al., 2015; Kotov et al., 2010). The 
results from Paper III demonstrated that HADS- A and HADS-D has a strong relationship to 
neuroticism and negative affect, and that what differentiates HADS-A and HADS-D is their 
relation to extroversion; a unique predictor of symptoms of depression but not anxiety when 
HADS was applied.   
Positive emotionality and cardiovascular health: Anhedonia and MI, the 
role of extroversion  
Although the role of Type A personality has been questioned, and perhaps rather dismissed 
(e.g. Smigelskas, 2015), personality, and more specifically, dispositional affect continues to 
be of interest in cardiac research (e.g. Roest et al., 2010: Lee et al., 2014; Jokela et al., 2013). 
Neuroticism has been central not because of its link to depression (Kotov et al., 2010; Ormel 
et al., 2013; Naragon-Gainey &  Watson, 2014; Watson & Naragon-Gainly, 2014) but also as 
a direct risk factor of  CVD (Jokela et al., 2013). The role of extroversion has until recently 
received less attention, but it is now recognized as having a specific relation to depression 
(Watson & Naragon-Gainly, 2014; Watson et al., 2015) and as being a more important 
predictor of CHD than neuroticism (Lee et al., 2015). Reduced positive affect predicts 
prognoses in cardiac patients (Denollet et al., 2007; Pelle et al., 2011; Damen et al., 2012) and 
the study by Davidson and colleagues (2010) demonstrated that positive affect protects 
against CHD, even when controlling for depression. The same is the case for positive 
psychological well-being (Boehm, Peterson, kivimaki, & Kubzansky, 2012). Given the 
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relationship between HADS-D and positive affect, and moreover, the prospective link 
between extroversion and HADS-D observed in Paper III, the results from Paper I and Paper 
III support the role of positive affect as a cardioprotective factor. The strong relationship 
between neuroticism, negative affect and HADS-A observed in Paper III further strengthens 
the argument that neuroticism/negative affect is less important as a risk factor of MI, as an 
elevated score on HADS-A was associated with a reduced risk of having an MI.  
The relationship between positive affect and CHD is probably more complex than portrayed 
so far in this study and in others. It might be that positive emotions work by their effect on 
buffering negative emotions and stress. In terms of cardiovascular reaction caused by negative 
emotions, extroversion is important in the experience of happiness and especially in 
rewarding situations that are social (Wilkowsky & Ferguson, 2014).  The results from paper 
III clearly showed that neither HADS-D nor extroversion is identical with low positive affect.  
A more differentiated view of what is referred to as anhedonia (e.g. Rømer-Thomson et al., 
2015) and knowledge about how extroversion is related to anhedonia and reward processes 
(Smillie, 2013) is important in future research. Extroversion might buffer the negative effects 
of neuroticism, and hence low extroversion might represent vulnerability when combined 
with neuroticism. This is consistent with the undoing hypothesis offered by Fredrickson and 
colleagues (1998; 2000) and their findings of positive emotions having a clear and consistent 
effect of undoing cardiovascular effects of negative emotions (i.e. blood pressure, heart rate 
and peripheral vasoconstriction). The recent focus on how positive affect is associated with 
prosocial behavior and internalizing problems in children (Wang & Saudino, 2015), and how 
positive affect moderates responses to positive and negative stimuli (Cunningham & 
Kirkland, 2014), can contribute in understanding the link between positive affect and 
depression. The fact that gender differences in positive affect and anhedonia is marginal to 
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non-existent (Costa et al., 2001; Snaith et al., 1995: Nakonezny et al., 2010) emphasizes the 
distinct features of anhedonia compared to other symptoms of depression.  
Gender differences in depression and risk of MI 
 
Women are overrepresented both in terms of diagnosis and higher symptom-level of 
depression (Piccinelli & Wilkinson, 2000; Alexandrino-Silva et al., 2013). In line with this, 
Paper II showed that, compared to men, women had significantly more often a history of 
depression (ĭ =.16).  However, except from the post-MI group in Paper II, men were 
significantly more depressed than women in the samples used in Papers I, II, and III using 
HADS-D.  Gender differences in depression vary across age (Faravelli et al., 2013; Altemus, 
et al., 2014), sub-type (Baune et al., 2006; Salakangas et al., 2002; Alexandrino-Silva et al.,  
2013) and symptom profile (Delisle et al., 2012). Paper III compared gender differences in 
negative and positive affect and personality trait associated with symptom reporting. The 
results from Paper III supported the idea that the reversed gender differences in depression 
could be, at least partly, explained by the focus on anhedonia in the HADS-D dimension. 
Consistent with other findings (e.g. Haukkala et al., 2009; Mendes de Leon et al., 1998), 
symptoms of depression were a stronger predictor of MI in women compared to men. 
Although not significant, there was a trend of symptoms of anxiety being more 
cardioprotective among men than women. History of depression was also a significant 
predictor of MI among men, but not women. HADS-D was a significant predictor of MI in 
men only when not controlling for other risk-factors, but was a very strong predictor (OR = 
3.68/2.31 unadjusted/adjusted) of incident MI among women.  As symptoms of MI in women 
differ from those in men, and that MI in women are more likely to occur asymptomatically 
(Coventry et al., 2011), the search for effective ways of screening is crucial. The results from 
this study strongly suggest that HADS can serve that mission.   
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Is HADS still important?    
In 2012, Coyne and Sonderen called for the abandonment of the Hospital Anxiety and 
Depression Scale based on the 10-year systematic review by Cosco and colleagues (2012).  
The results from Paper III adds to the debate regarding the validity of HADS-D as a general 
measure of depression due to the moderate relationship between HADS-D and neuroticism, 
compared to HADS-A. Also, in Paper II, history of depression was more strongly related to 
HADS-A than HADS-D.  The reversed gender differences observed in Papers II and III 
further advocates cautious use of the instrument. So why is HADS still important? An 
elevated score on HADS-D represents a strong predictor of MI among women free of CHD at 
baseline. Using HADS-D to identify those at risk and providing interventions that reduce the 
risk could, therefore, save lives. Martin (2005) has asked what HADS measures in a 
psychiatric setting. To understand the role of psychological variables in the etiology of CHD, 
the timely question is, what does it measure in a general population? This study contributes to 
this understanding and emphasis that HADS-D measure an anhedonic subtype of depression 
that reflects dispositional tendencies. The content in HADS-D imposes both limitations and 
possibilities for future use of HADS. The request for more specific measurement of 
depression in research on the etiological link between depression and CHD (Doyle et al., 
2010; Hawkins et al., 2013) suggest that HADS (Zigmund & Snaith, 1983) has a future within 
cardiac research. While Papers I and II give a clear answer to why HADS is still important; 
Paper III offers an answer on how HADS is important.   
 
Heterogeneity, comorbidity and complexity as reasons for inconsistency in 
findings  
In a substantial part of the research on depression and CVD, the outcome-variable has 
consisted of a non-specific CVD incident category comprising MI, stroke as well as other 
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coronary or vascular conditions.  However, the biological mechanism representing these 
relationships may vary substantially for coronary versus vascular incident. A CVD outcome 
variable might be comprised of both fatal/non-fatal CHD and stroke events. Jokela and 
colleagues (2013) found that extroversion was negatively associated with CHD-mortality (not 
significant), but also that extroversion was significantly and positively associated with 
increased stroke-mortality. In the study by Lee and colleagues, only CHD incidents were the 
outcome variable. This emphasizes the importance of being specific both in terms of 
predictors and outcome, and hence the results from this study should not be generalized to 
CVD events in general.  
Anxiety has been found to be associated with reduced mortality (Mykletun et al., 2007). 
Further, while panic disorders increase the hazard of MI for those less than 50 years, it 
reduced CHD-mortality at all ages (Walters et al., 2008). Future studies could benefit from 
investigating differences in non-fatal and fatal events as anxiety and depression have a general 
effect on mortality not limited to CVD events (Mykletun et al., 2007). Although a request for 
a more specific measurement of depression and anxiety has been made by several researchers 
(e.g. Baatelan et al., 2014; Baune et al., 2012; Davidson, 2012; Tully et al., 2015), focus on 
high specificity in the outcome variable should be an aim, as well as gender-specific analysis. 
The comorbidity of anxiety and depression further dilute the picture. The nature of 
comorbidity is yet unknown and whether anxiety precedes depression or vice versa is still 
debated (Cummings et al., 2014). In Paper II, symptoms of anxiety measured at HUNT 2 were 
a stronger predictor of depression measured at HUNT 3 than depression measured at HUNT 2 
was of anxiety at HUNT 3. This indirectly supports the idea that anxiety precedes depression, 
at least at symptom level, and can explain why anxiety diagnosis received at a younger age 
predicts CVD events in later life (i.e. Janszky et al., 2010). Regardless, the relationship 
between symptoms of depression and CHD is complex, and dispositions in experiencing 
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negative and positive affect and stress-proneness interacts with life circumstances. The 
environmental influences should not be overlooked and stressful life events are found to 
interact with the relationship between personality and symptom-reporting (Hundt et al., 2007). 
Furthermore, the findings of how neuroticism interacts with socioeconomic status (Hagger-
Johnsen et al., 2012) suggest that neuroticism might be cardioprotective for those having the 
resources to attend to health worries, whereas the opposite is the case for those less fortunate 
in terms of income and education. The combination of traits is also important, and the 
combination of high neuroticism and low extroversion is important in explaining symptom 
reporting (Watson & Naragon-Gainey, 2014). The biologically-based brain system BIS and 
BAS (closely related to neuroticism and extroversion) jointly predicts symptoms of anhedonic 
depression, especially encounters with stressful life events (Hundt et al., 2007).  However, in 
terms of mental disorders, like major depression, other personality traits, especially 
conscientiousness, are important (Kotov et al., 2010). The way personality influences health is 
complex. Personality traits dynamically influence health, directly through bodily sensations 
and symptom reporting as well as mortality, and more indirectly by the means of social 
cognition, health behavior and coping (Ferguson, 2013). Recent advances in the physiological 
approach to personality, like the study of personality and cardiovascular reactivity (Jonassaint 
et al., 2009: Kelly-Hughes, Wetherell &, Smith, 2014), other physiological correlates 
(Brouwer, van Schaik, Korteling, van Erp & Toet, 2015), and brain structure (DeYoung et al., 
2010) as well as function (Cunningham & Kirkland, 2014) might be a promising approach to 
better understand the link between personality and CHD.  
 
Broad dispositions or specific sub-types of depression and anxiety 
While arguing the importance of broad disposition, the need to focus on specific sub-types or 
phenotypes of anxiety depression is emphasized in cardiac research (e.g. Doyle et al., 2010; 
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Hawkins, et al., 2013; Baatelan et al., 2014; Tully et al., 2015). Although the focus on both 
broad dispositions apparently contradicts the request for focusing on specific symptom 
clusters, this might not be the case. Negative and positive affect is viewed as two dominant 
higher-order dimensions (Watson & Tellegen,1985), while at the same time being 
operationalized as specific symptom clusters (Hawkins et al., 2014). In more recent theories 
on the organization of human personality, it has been suggested that the traits in the five factor 
model can be organized under these two basic dimensions, namely positive and negative 
affect (DeYoung, 2010).   
Given the strong relationship between HADS-A, neuroticism, negative affect and history of 
depression observed in Papers II and III, the reversed relationship between HADS-A and MI 
is somewhat surprising, especially since perceived stress is associated with cardiac events 
(Katsarou et al., 2014) and the role of neuroticism in both symptom reporting and common 
mental disorders (Kotov et al., 2010). However, a recent meta-analysis of prospective studies 
has concluded that depression, measured by self-report as well as clinical diagnosis; 
represents an increased risk of CHD (Cohen et al., 2015; Gan et al., 2014). While the 
differentiation of negative affect into e.g. anxiety, disgust, depression and hostility has a long 
history, positive emotions seem to be less differentiated (Egloff et al., 2003). However, the 
different items HADS-D representing positive affect or anhedonia, have been found to have 
differentiated prognostic value (Denollet et al., 2007), addressing the need of specificity in 
predictors. At the same time, broad personality dimensions have been found to predict CHD 
events (Lee et al., 2014; Jokela et al., 2013).  An established view is the differentiation of both 
positive and negative emotions in terms of activation vs. deactivation and pleasantness vs. 
unpleasantness (Barrett & Russell, 1999). Different models exist; however, the tripartite 
model of Clark and Watson (1991) can best account for the relationship between positive and 
negative affect in terms of related, but not bipolar dimensions, as the negative correlation 
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between positive and negative affect varies from non-existent, weak to moderate (Barrett & 
Russell, 1999). Future cardiac research should aim at integrating broad dispositions as well as 
specific symptom clusters. The focus on anhedonia is one of many ways to unravel the 
psychological etiology of CHD.  
 
Anhedonia as a risk of incident MI: implications for screening and 
treatment  
 
Papers I and II showed that symptoms of depression measured by HADS-D increased the risk 
of an MI, although the risk estimate was not significant for men when controlling for all of the 
established risk factors. Treatment of depression with selective serotonin reuptake inhibitors 
has been found to diminish neural processing of reward stimuli (McCabe et al., 2010). 
Impairment in reward processes is a central component in anhedonia (Römer-Thomson et al., 
2015), and it is likely that antidepressants other than SSRI would be more suitable for the 
pharmacological treatment of anhedonia. Agomelatine, one of the most recent antidepressants, 
affects both the release of noradrenaline and dopamine, and has been suggested to be superior 
to other pharmacological treatments of symptoms of anhedonia, and of major depression in 
general (De Berardis et al., 2015; Kennedy & Cyriac, 2012). Furthermore, the role of 
dispositional anhedonia might also have implications for depression treatment in general as 
Takahashi and colleagues (2013) suggest that the personality trait (low) reward dependence is 
a risk factor for treatment-resistant depression. A randomized controlled study of internet-
based cognitive behavioral therapy as a treatment of anxiety in depression in MI patients 
using HADS as the main measure is outlined (Norlund, Olsson, Burell, & Held, 2015). 
Although not directly transferable to a general population, the forthcoming results from this 
study can inform the development of effective treatment of anhedonia.  
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Limitations 
The results from Paper I suggest that having an MI did not significantly impact the level of 
symptoms of anxiety and depression on a long-term basis, but the conclusions based on these 
results call for caution. Analyses of the participation in the follow-up HUNT 2 and HUNT 3 
conclude that participation is associated with survival, socioeconomic status and symptoms 
(Langhammer et al., 2012). Therefore, those severely depressed after MI were less likely to 
participate in HUNT 3. Furthermore, the results cannot be transferable to a short-term effect 
of having MI due to the long duration since MI. In Samples I and II, the sample size is very 
large. This means that the statistical power is very high, higher than the recommended 
standard criteria of .80 (Cohen, 1992). To counter this, effect sizes were included in all 
results. It should be noted that the effect size in Paper I is small (OR 1.04). However, it is 
important to remember that symptoms of depression were operationalized as a continuous 
variable, and that even a change from “Not at all” to “Not often” would constitute a change in 
risk estimate. The effect size of HADS-D operationalized as HADS 8 logically shows a 
much stronger effect. The relatively moderate correlation between neuroticism and depression 
measured by HADS, could also, in part, be explained by somewhat low internal consistency 
in the dimension and the skewness in the distribution of the variable. In Paper III, the sample 
consisted of university students, and there should be some caution regarding generalization. 
However, the gender differences observed in HADS presented the same pattern as the 
community sample applied in Paper II. It should also be mentioned that this study does not 
directly address the impact of personality traits on risk of MI, and the role of extroversion as a 
risk factor of MI is suggestive and indirect more than empirically documented in this study.  
Future research  
Heterogeneity in type of sample, predictors, assessment and outcome is why firm conclusions 
about anxiety and depression as risk factors of CVD cannot be yet drawn. It has been argued 
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that gender should be included in all investigative CVD models (Orth-Gomer & Deter, 2015). 
Waist-hip ratio is a strong physical risk indicator where gender-specific cut-off scores are 
being applied. It is time to move forward in regards to psychological variables, as well. Men 
and women do not represent an identical population, neither in regards to biological aspect 
nor psychological profiles. In the future, a clearer distinction should be made on general 
population versus CVD patients. To understand the role of psychological variables in the 
etiology of CVD, large-scale prospective studies on subjects free of CVD at baseline should 
be encouraged. The role of dispositional affect should be incorporated as stable tendencies not 
only might represent an independent risk factor in the etiology of CVD but also represent 
vulnerability and resilience toward several psychological conditions known to be associated 
with risk on CVD. Measurement that is specially designed to measure anhedonia (Leventhal 
et al., 2006) should be applied in the future research to increase knowledge about the role of 
anhedonia as a risk factor of MI.  Furthermore, CVD as an outcome should not be treated as 
one single outcome. The relationship between specific psychological variables relates in 
differentiated ways to specific outcomes. Focusing on more specific outcomes allows more 
accurate investigation. There is reason to suggest that it would be wise to separate fatal and 
non-fatal outcomes given the general relationship between depression, anxiety and mortality. 
Most importantly, the operationalization of anxiety and depression is crucial.  
Conclusion 
The conclusions from this study can be summarized in the following way. Elevated symptoms 
of depression measured by HADS increases the risk of incident MI. Although limitations 
apply, having an MI does not have long-term adverse effects on the level of symptoms of 
anxiety and depression, and time since MI was not a significant predictor of symptom level.  
Second, there were gender differences in the MI-risk estimate based on HADS-D. A HADS-D 
score above seven was a significantly stronger predictor of incident MI among women than 
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men.  History of depression was a significant predictor of MI among men, but not women, 
further emphasizing the need for gender-specific psychological risk profiles. Elevated 
symptoms of anxiety measured by HADS represented a reduced risk of having an incident MI 
among both men and women. Finally, HADS presented a relationship to positive and negative 
affect consistent with the tripartite model of anxiety and depression. The dimensions in 
HADS presented high test-retest stability and a strong relationship to the personality traits 
neuroticism and extroversion. The results supported that the HADS depression subscale 
represents an anhedonic type of depression, and that the anhedonic content in the depression 
subscale can account for the reversed gender differences in depression observed in this and 
other samples.  
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Women have been marginalized in the field of cardiac 
research, and studies focusing specifically on women’s 
psychological risk profiles are lacking (Naqvi et al., 2005; 
Wenger, 2003). Coronary heart disease (CHD) in women 
does not present or manifest the same way as in men; symp-
toms of myocardial infarction (MI) are more atypical and 
cardiac events more likely to occur asymptomatically. 
Women are less likely to experience chest pain before an 
MI than men, but significantly more likely to experience 
neck pain, nausea, right-arm pain, dizziness, jaw pain and 
fatigue (Coventry et al., 2011). Furthermore, women typi-
cally experience a heart attack later in life than men and 
hence have more comorbid conditions, and they are also 
less likely to be diagnosed and treated efficiently (Low 
et al., 2010; Möller-Leimkühler, 2007). The European 
guidelines on cardiovascular disease (CVD) prevention in 
clinical practice (Perk et al., 2012) emphasize the inclusion 
of psychosocial factors in CHD risk assessment. However, 
the guidelines offer no gender-specific risk profile in regard 
to anxiety and depression.
Several reviews about the relationship between depression 
and CHD (e.g. Nicholson et al., 2006; Stampfer et al., 2012; 
Van der Kooy et al., 2007; Wulsin and Singal, 2003) and pro-
spective studies (e.g. Gustad et al., 2013; Hawkins et al., 
2013) strongly support that there is an association between 
depression and CHD. Among women, there has been an 
increased prevalence of CHD, and the role of depression as a 
gender-specific factor is still unclear (Naqvi et al., 2005). In a 
Finnish study, symptoms of depression predicted cardiovas-
cular mortality only in women (Haukkala et al., 2009). In 
another study, depressive symptoms were an independent risk 
factor for CHD in women but not in men (Mendes de Leon 
et al., 1998), and depressive symptomatology has been found 
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to be more important in predicting CVD in women than in 
men (Lloyd et al., 1996). In contrary, a French population-
based study found that depressive mood predicted cardiovas-
cular mortality for men only (Lemogne et al., 2012). These 
findings emphasize the importance of both screening for 
depression in general and a focus on the gender-specific role 
of depression in preventive heart interventions.
Women and men represent different populations, and 
therefore, the practice of using men as references should be 
reconsidered (Wenger et al., 2008). Prevalence, incidence, 
and morbidity risk of depressive disorders are higher in 
females than in males (Piccinelli and Wilkinson, 2000). 
Different measures of depression tend to display differenti-
ated gender differences (Salokangas et al., 2002), and in 
some self-report instruments, the differences are reversed, 
that is, men have a higher score on depression (Nortvedt 
et al., 2006; Stordal et al., 2001). At the symptom level, dif-
ferent gender subtypes can be identified (Alexandrino-Silva 
et al., 2013), and this might have implications for under-
standing the depression–CHD relationship. Gender differ-
ences in depression differ from gender differences in CHD, 
suggesting that the association between depression and CHD 
is gender specific (Faravelli et al., 2013; Low et al., 2010).
In medical practice as well as in the research field 
addressing depression and CHD, a variety of operationali-
zations of depression exist (Davidson, 2012; Davidson 
et al., 2005; Stampfer et al., 2012). The relationship between 
affective disorders and CHD seems to vary in strength by 
subtype (Baune et al., 2012). The treatment of depression 
as a unidimensional construct in the research field has left 
several questions unanswered regarding symptom clusters 
(Hawkins et al., 2013) and whether some aspects or sub-
types of depression are more cardiotoxic than others (Doyle 
et al., 2010). Furthermore, different symptomatic profiles 
of depression have been identified in men and women 
(Alexandrino-Silva et al., 2013), so including gender- 
specific analysis is important in understanding the role of 
depression as a risk factor of CHD. It is also possible that 
gender-specific strategies could improve the predictive 
power of a psychological risk profile, but prospective stud-
ies are needed to identify gender-specific risk profiles.
Shaffer et al. (2012) address the importance of research 
on different depression phenotypes and emphasize the role 
of anhedonic depression in the association between depres-
sion and CHD. Recent research on MI has emphasized the 
role of anhedonia (reduced positive affect and loss of inter-
est and pleasure and lack of reactivity to usually pleasura-
ble stimuli) as independently associated with MI (Davidson 
et al., 2010; Denollet et al., 2007). Anhedonia, which refers 
to the reduced or lost capacity to experience pleasure, is a 
feature of major depressive disorder (Di Giannantonio and 
Martinotti, 2012). An emphasis on the distinction between 
depressive syndromes and symptoms and the examination 
of the predictive ability of different operationalization has 
also been requested (Davidson et al., 2005).
Although the study of psychological risk factors of CHD 
has mainly focused on depression, there is a growing 
amount of literature on the link between anxiety and the 
development of CHD (Batelaan et al., 2014; Roest et al., 
2010; Tully et al., 2013). However, the heterogeneity in 
assessment of anxiety imposes major limitations in the 
investigation of the impact of anxiety (Batelaan et al., 
2014). Generalized anxiety disorder (GAD), but not symp-
toms of anxious arousal, has been found to predict mortal-
ity in CHD patients (Tully et al., 2011). In another study, 
symptoms of anxiety predicted mortality in CHD patients 
independent of symptoms of depression (Watkins et al., 
2013). In a study of middle-aged women, a three-item 
measure of symptoms of anxiety predicted fatal cardiovas-
cular incidents (Denollet et al., 2009). In contrast, the study 
by Mykletun et al. (2007) showed that symptoms of anxiety 
were negatively associated with cardiovascular mortality. 
Similarly, others have documented that higher anxiety 
scores are associated with reduced mortality (Meyer et al., 
2010). Furthermore, GAD has been found to predict supe-
rior outcome after an acute coronary syndrome (Parker 
et al., 2011). Other studies have found that symptoms of 
anxiety are not associated with CHD events when control-
ling for depression (Versteeg et al., 2013). Furthermore, 
gender differences in anxiety are highly prevalent, and 
comorbidity between the disorders is higher among women 
(McLean et al., 2011). It is therefore important to include 
measures of anxiety in the search for a gender-specific psy-
chological risk profile.
The European guidelines on CVD prevention (Perk 
et al., 2012) do not specify how depression should be meas-
ured and offer no gender-specific recommendations. This 
study addresses the value of using simple psychological 
screening tools in order to identify men and women at risk 
of having an MI based on their psychological profile.
Although highly comorbid in psychiatric clinical sam-
ples, the comorbidity rates between anxiety and depression 
in CHD patients are substantially lower (Tully and Cosh, 
2013). This is also the conclusion made by Hek et al. 
(2011): Comorbid depression and anxiety are less prevalent 
in older adults, while current anxiety disorders are substan-
tially related to past depression. In this prospective, popula-
tion-based study, a unique linkage between a large health 
survey, clinical assessment, and the national mortality reg-
ister is utilized. This enables the investigation of the roles 
of anhedonic depression, depressive episode, and anxiety 
as gender-specific risk factors of MI.
Method
Study design and participation
The Nord-Trøndelag Health Study (The HUNT Study) is col-
laboration between the HUNT Research Centre (Faculty of 
Medicine, Norwegian University of Science and Technology 
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NTNU), the Nord-Trøndelag County Council, the Central 
Norway Health Authority, and the Norwegian Institute of 
Public Health. HUNT is one of the largest health studies ever 
conducted and is described in Holmen et al. (2003). It is a 
large database of personal and family medical histories col-
lected during three intensive studies over two decades. 
HUNT1 was carried out from 1984 through 1986 to establish 
the health history of 75,000 people. The succeeding HUNT2 
was carried out from 1995 through 1997 and focused on the 
evolution of the health history of 65,049 people. HUNT3 was 
completed in June 2008, and 48,289 people participated (52% 
participation rate). Data were collected by means of question-
naires, interviews, clinical examinations, and collection of 
blood and urine samples.
Of the 65,049 people who participated in HUNT2, those 
with a history of MI or reported current or previous inci-
dents of angina were excluded from the analyses. 
Participation in the HUNT3 study or identification in the 
mortality register was used as the inclusion criteria, result-
ing in 41,248 candidates for this study. A total of 573 partici-
pants in the HUNT3 study (2.5%) reported that they 
currently or prior to the examination had a non-fatal MI. 
According to the mortality register, 249 were classified with 
mortality due to MI, that is, having a fatal MI. The Regional 
Committee for Ethics in Medical Research approved the 
protocols for HUNT2, HUNT3, and for this specific study, 
including the linkage to the mortality register. All partici-
pants in this study gave their written consent.
Measurement of depression and anxiety
The Hospital Anxiety and Depression Scale (HADS; 
Zigmond and Snaith, 1983) includes 14 items with a 4-point 
scale indicating how the respondent has felt over a 2-week 
period prior to measurement. HADS has been found supe-
rior to other depression scales when measuring cardiotoxic 
symptoms, as HADS focuses mainly on anhedonia (Doyle 
et al., 2012). However, HADS does not include somatic 
symptoms, a symptom cluster identified as important in 
relation to CHD (Hawkins et al., 2013).
The HADS anxiety scale contains items that cover wor-
rying, restlessness, and panic attacks. It has been proven to 
have good clinical value and case-finding abilities (Olssøn 
et al., 2005). In the depression subscale, the dominant focus 
is on anhedonia (Mykletun et al., 2001). In this study, a 
Norwegian translation of HADS was used (Mykletun et al., 
2001). A score on HADS-A and HADS-D t8 on the respec-
tive scales was used as an indicator of case-level anxiety 
and depression (Bjelland et al., 2002).
Depressive episode
In an extended part of the HUNT2, the participants were 
instructed to indicate whether, during their life, there had 
been periods of two consecutive weeks or more when they 
“felt depressed, sad, and down,” “had appetite problems or 
ate too little,” “felt weak (adynamic) or lacked energy,” 
“really reproached yourself and felt worthless,” or “had 
problems concentrating or had difficulty making decisions.” 
Participants were classified as having experienced a depres-
sive episode if they answered yes to the question, “During 
your life, have there been periods of two consecutive weeks 
or more when you had at least three of the above-mentioned 
problems simultaneously?”
Hypertension, cholesterol, waist–hip ratio
Participants’ systolic blood pressure (SBP) was measured 
by specifically trained nurses using a cuff adjusted for 
arm circumference in HUNT2. SBP was measured three 
times, and a mean was calculated from the second and 
third observations to ensure reliable measurements. Total 
serum cholesterol was measured applying an enzymatic 
colorimetric cholesterol esterase method (Holmen et al., 
2003). Waist and hip circumferences were measured with 
a steel band to the nearest 1.0 cm with the participant 
standing and with the arms hanging relaxed. The waist 
circumference was measured horizontally at the height of 
the umbilicus, and the hip circumference was measured at 
the thickest part of the hip (Holmen et al., 2003). The 
International Diabetes Federation (IDF) has also provided 
recommendations for cut-offs for waist circumference and 
waist–hip ratio. The recommendations are gender, popu-
lation, and geography specific. For Europeans, the recom-
mended cutoff scores are .80 for women and .94 for men 
to identify central obesity (Alberti et al., 2006).
Diabetes and smoking
Smoking was self-reported and operationalized as numbers 
of years of daily smoking. Diabetes was also self-assessed 
by answering yes or no.
End point: fatal and non-fatal MI
The mortality data were obtained from the National Mortality 
Register by combining the mortality database and the HUNT 
data by means of an 11-digit personal identity number. In the 
mortality registry, diagnoses are encoded according to 
International Classification of Diseases, 10th Revision (ICD-
10). MI mortality in this study encompasses ICD-10 codes 
I21-9, unspecified acute MI, and I22-9 subsequent MI with 
unspecified location, with the majority of cases being I21-9. 
Non-fatal MI was indicated by self-report in the HUNT3 
study as a “yes” or “no” response to the question, “Have you 
ever had or do you have myocardial infarction?”
Statistical analysis
Independent-samples t-test and χ2 were conducted to com-
pare the groups on the baseline characteristics at HUNT2. 
Logistic regressions were applied to investigate the effect 
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on MI. The dependent variable was dichotomous (MI/non-
MI). Separate analyses were performed for men and women 
to enable comparison of the risk predictor’s gender-specific 
magnitude. The psychological variables were entered in 
Step 1, whereas the traditional risk factors were entered in 
Step 2 to adjust the model.
Results
In the total sample of 41,248 subjects, 822 of the partici-
pants had a fatal (249) or non-fatal (573) MI. Of those with 
a HADS-D score t8 (3621), 59.3 percent (2148) had a 
HADS-A score t8, and 5.7 percent (2148) had a history of 
depressive episode. Compared to men, women reported 
higher prevalence of prior depressive episode (6597/22,013 
vs 3060/18,413, χ2 = 982.81 (1), Φ = 16, p < .001). Women 
were overrepresented in the HADS-A t8 group as 1907 out 
of 2203 women had a HADS-A score equal or above 8, 
whereas the respective numbers for the men were 2291 out 
of 18,413 (χ2 = 317.71 (1), Φ = .07, p < .001). Men were 
marginally overrepresented in the HADS-D >8 group; 1714 
out of 18,413 men and 1907 out of 22,013 women had a 
HADS-D score t8 (χ2 = 5.12 (1), Φ = .01, p < .03. Analysis 
between the outcome variable MI versus non-MI group and 
predictors performed by t-test and χ2 showed significant 
associations and group differences related to all predictors 
except depressive episodes. The prevalence of elevated 
symptoms of anxiety was higher in the non-MI group, 
although this association was significant only for men. 
Prevalence of depression measured by HADS-D was sig-
nificantly different in the MI versus the non-MI group in 
both men and women, whereas depressive episodes were 
not. There was a significant association between HADS-D 
and depressive episode (Φ = .25, p < .001) and a significant 
association between HADS-D and HADS-A (Φ = .39, 
p < .001). HADS-A and depressive episode had a signifi-
cant positive association (χ2 = 4498.32 Φ = .33, p < .001; 
Table 1).
Table 2 shows the results of the logistic regression. In 
the total sample, elevated symptoms of depression (>8) 
were a significant predictor of MI, whereas history of 
depression was not. After adjusting for the traditional risk 
factors (gender, cholesterol, waist–hip ratio, diabetes, 
smoking, and SBP), history of depressive episode emerged 
as a significant predictor along with symptoms of depres-
sion. A high score on anxiety (HADS-A >8) significantly 
reduced the risk of having an MI both in the unadjusted 
and adjusted model. In the separate analysis, history of 
depression was not a significant predictor of MI in the 
female sample. Elevated symptoms of depression increased 
the odds of having an MI, whereas the opposite was the 
case for anxiety. Higher score on HADS-A represented 
reduced risk of having an MI in the male sample, and the 
effect size (odds ratio (OR)) of this predictor was stronger 
compared to the female sample in both the unadjusted and 
adjusted model. History of depressive episode was a sig-
nificant predictor of MI in men, and elevated symptoms of 
depression were a significant predictor only in the unad-
justed model.
Post hoc analyses of risk differences
To investigate whether the gender differences in risk were 
statistically significant, the statistical approach suggested 
by Paternoster et al. (1998) was applied. In this procedure, 
a Z-score is calculated, and according to the results, there 
was a significant difference in risk estimate based on 
HADS-D; Z = 2.96, p = .002. The difference in risk-based 
anxiety (Z = .62) and history of depression (Z = 1.57) did not 
reach statistical significance.
Discussion
Women have been marginalized in the search for psycho-
logical risk factors for CHD, and prospective studies apply-
ing separate analyses for men and women have been 
Table 1. Demographic and baseline risk factors in MI (822) versus non-MI group (40,426) sorted by gender (N = 41,248).
Women (22,013) Men (18,413)
Non-MI 
(21,771)
MI (242) p d Non-MI 
(17,833/17,759)
MI (580) p d 
Age 43.12 (13.07) 57.87 (9.31) .001 43.61 (12.90) 55.81 (9.44) .001
Systolic blood pressure 129.30 (19.02) 148.31 (23.94) .001 136.93 (16.36) 146.73 (18.17) .001
Total cholesterol 5.69 (1.24) 6.94 (1.20) .001 5.72 (1.14) 6.50 (1.07) .001
Diabetes (n) 251 (1.2%) 13 (5.4%) .001 295 (1.7%) 22 (3.8%) .001
WHR (n) 8001 (37.4%) 148 (61.7%) .001 2702 (15.20%) 167 (28.8%) .001
Smoking N years 9.85 (12.10) 19.37 (16.68) .001 11.55 (13.72) 23.31 (15.57) .001
Depression cutoff t8 1855 (8.5%) 52 (21.51%) .001 1645 (9.2%) 69 (11.9%) .03
Anxiety cutoff t8 (n) 3826 (17.6%) 43 (17.8%) .94 2244 (12.6%) 47 (8.1%) .001
Depressive episode (n) 6514 (29.9%) 83 (34.3%) .14 2949 (16.5%) 111 (19.1%) .10
0,: myocardial infarction; WHR: waist–hip ratio.
χ2 and t-test for bivariate association between MI and non-MI group.
Langvik and Nordahl 5
requested (Low et al., 2010; Naqvi et al., 2005; Wenger 
et al., 2008). In this study, different psychological risk pro-
files among men and women were identified and support the 
assumption that the association between depression and 
CHD is gender specific (e.g. Faravelli et al., 2013; Low 
et al., 2010). Depression, especially symptoms of anhedonic 
depression as measured by HADS, seems to be a strong pre-
dictor of MI among women, whereas this specific instru-
ment did not contribute in predicting MI among men after 
controlling for traditional risk factors. Post hoc analysis of 
differences in risk estimate showed that this difference was 
statistically significant. This is consistent with other find-
ings of symptoms of depression being more important in 
predicting CHD in women than men (Lloyd et al., 1996). 
History of depressive episodes was more prevalent in 
women and was a significant risk predictor in men only; 
however, the gender difference in risk was not significant. 
Although HADS-D and depressive episodes were correlated 
(Φ = .25), the strength of the relationship between do not 
suggest that these differences could be attributed to co- 
linearity. It rather supports the view that men and women 
represent different populations when it comes to 
understanding the link between depression and CHD 
(Wenger et al., 2008). The higher prevalence of history of 
depressive episodes in women might be the reason that it 
fails to differentiate those at risk of MI. The results support 
that gender differences in depression are important to incor-
porate in understanding the link between depression and 
CHD. Elevated symptoms of depression (HADS-D t8) 
were not more prevalent in women, and this is consistent 
with other studies using HADS (e.g. Nortvedt et al., 2006; 
Stordal et al., 2001). However, the results in this study are 
contrary to comparable samples where other measurements 
of depression have been applied (e.g. Mendes de Leon et al., 
1998) and the general literature on gender differences 
(Piccinelli and Wilkinson, 2000). This suggests that HADS-D 
represents a distinct symptom cluster of depression that 
might be especially cardiotoxic for women. HADS does not 
include somatic symptoms, and HADS-D focuses mainly on 
anhedonia (Mykletun et al., 2001). Although the somatic 
cluster has been identified as the most important symptom 
cluster in predicting CHD (Hawkins et al., 2013), this study 
found that other symptom clusters of depression are relevant 
and that positive affect may be cardioprotective, especially 
for women. Hawkins et al. (2013) identified somatic clusters 
followed by positive affect as the most important symptom 
clusters predictive of CHD, but the analyses were not per-
formed separately for men and women, and the role of spe-
cific symptom clusters as more cardiotoxic can only be 
understood by prospective studies including participants free 
of CHD at baseline. Furthermore, separate data analysis 
should be performed, not only controlling for gender (Low 
et al., 2010). The variable “Depressive episode” includes 
both somatic symptoms and lack of positive affect/depressed 
affect, and it might be that somatic clusters are more impor-
tant for men than for women. A lifetime history of depressive 
episodes was a unique predictor of MI in men and not women 
in the adjusted models.
HADS does not include somatic symptoms, and this 
methodological aspect might be the reason why studies 
using HADS-A (e.g. Versteeg et al., 2013), including this 
study, do not find a positive association between anxiety 
and CHD. However, the study by Parker et al. (2011) using 
diagnostic criteria for GAD did find the same results as in 
this study, that is, anxiety being cardioprotective. Although 
distinctive conditions, the relationship between HADS-A 
and GAD is well documented (Olssøn, et al., 2005)
It is important to differentiate between anxiety and 
depression as a prognostic factor in CHD groups and risk 
factor of CHD in healthy populations. While the prognostic 
studies focus on patients with existing CHD, the etiologic 
approach focuses on psychological factors as risk factors of 
CHD, and these represent two different approaches 
(Nicholson et al., 2006; Stampfer et al., 2012). As sug-
gested by Parker et al. (2011), timing is of great impor-
tance, and both anxiety and depression might have quite 
different roles as etiological factors compared to prognostic 
Table 2. Results of logistic regression.
Variables OR (CI) p < 
Psychological variables (total sample)
 Unadjusted
  HADS-D t8 2.42 (1.93–3.02) .001
  HADS-A t8 .49 (.38–.63) .001
  Depressive episode 1.00 (.84–1.19) .98
 Adjusted
  HADS-D t8 1.41 (1.12–1.78) .003
  HADS-A t8 .61 (.50–.79) .001
  Depressive episode 1.29 (1.07–1.55) .008
Psychological variables (women)
 Unadjusted
  HADS-D t8 3.68 (2.52–5.37) .001
  HADS-A t8 .59 (.40–.89) .011
  Depressive episode 1.02 (.75–1.37) .92
 Adjusted
  HADS-D t8 2.31 (1.57–3.40) .001
  HADS-A t8 .65 (.43–.98) .038
  Depressive episode 1.05 (.77–1.43) .747
Psychological variables (men)
 Unadjusted
  HADS-D t8 1.66 (1.25–2.20) .001
  HADS-A t8 .45 (.32–.63) .001
  Depressive episode 1.36 (1.09–1.71) .008
 Adjusted
  HADS-D t8 1.11 (.83–1.48) .500
  HADS-A t8 .55 (.40–.78) .001
  Depressive episode 1.44 (1.14–1.82) .002
CI: confidence interval; OR: odds ratio; HADS: Hospital Anxiety and 
Depression Scale.
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factors. However, the findings of this study of anxiety as a 
protective factor of MI in healthy subjects are consistent 
with studies of patients with acute coronary syndrome, 
where anxiety predicted superior 5-year outcomes (Parker 
et al., 2011). Men are more reluctant to self-refer to primary 
health care (Jeffries and Grogan, 2012), and this might be 
why the protective effect of anxiety is stronger for the male 
sample in this study. Although females were underrepre-
sented, the review of seven etiological studies of initially 
disease-free individuals points to worry as being associated 
with fatal and non-fatal CHD (Tully et al., 2013). Limited 
knowledge about anxiety and CHD has been attributed to 
the assessment of anxiety, and worry has been found 
to have the strongest impact on the onset of CVD compared 
to panic and phobias (Batelaan et al., 2014). More knowl-
edge about the association between depression and anxiety 
can be achieved through the focus on the differential impact 
of types of anxiety (Batelaan et al., 2014) informed by the 
focus on specific symptom cluster/phenotypes of depres-
sion (Hawkins et al., 2013; Shaffer et al., 2012). A higher 
level of specificity might be a promising approach toward a 
more comprehensive understanding of anxiety as a risk or 
protective factor of CHD in general and MI in particular for 
men and women.
Treatment of depression in CHD patients thus far has 
demonstrated only moderate effects (Baumeister et al., 
2011), especially among women (Low et al., 2010). 
However, treatment of depression before the onset of CHD 
has been found to reduce the risk of CVD (Stewart et al., 
2014). This points to the importance of primary prevention 
and suggests that addressing depression as a risk factor has 
more impact than the treatment of depression as a prognos-
tic factor, and hence interventions should aim at screening 
those at risk. Effective and simple screening for depression 
in identifying CHD risk in non-cardiac patients could 
reduce the number of MI deaths among men and women. 
Screening for depression would have a positive impact 
regardless of its association with CHD as depression repre-
sents a major health problem (Möller-Leimkühler, 2007).
In the research on depression and CHD, depression has 
been treated as a unidimensional cluster, whereas more 
recent studies have demonstrated that particular depressive 
symptoms are stronger predictors (Hawkins et al., 2013), 
and the role of anhedonia has received particular attention 
(Davidson et al., 2010; Denollet et al., 2007; Shaffer et al., 
2012). The implication of anhedonia as a specific cardio-
toxic symptom is that this symptom cluster or depression 
subtype, or intermediary phenotype, should be more care-
fully addressed in the preventive strategies (Shaffer et al., 
2012). It is also possible that the type of treatment has not 
been optimal for women (Low et al., 2010; Naqvi et al., 
2005). In the research on anhedonia in major depression, 
agomelatine has shown promising results (Di Giannantonio 
and Martinotti, 2012). The potential of agomelatine to 
reduce the risk of CHD in patients with an anhedonic 
depression subtype should be explored as a possible new 
intervention in prospective studies applying a gender- 
specific approach.
Efficient ways of identifying women with increased 
CHD risk due to psychological factors is necessary in order 
to develop effective prevention and intervention strategies 
(Low et al., 2010). This study suggests that HADS-D could 
be used to identify risk in women, whereas information 
about lifetime depression/depressive episode is more prom-
ising in identifying risk among men. Both represent simple 
and non-invasive approach that easily could be adopted by 
health personnel. Anxiety as measured by HADS-A is not a 
suitable screening tool in identifying risk, according to the 
results of this study, which is in line with other studies that 
have used HADS to explore the association between anxi-
ety and CHD (Versteeg et al., 2013). Further research 
should address whether symptoms of anxiety might be pro-
tective of MI in a general population.
It has been argued that it is premature to conclude that 
depression in general is an independent causal risk factor 
for CHD (Stampfer et al., 2012). The findings from this 
study support this notion, as it seems that too little is known 
about the specific aspects of depression as a CHD risk fac-
tor in men and women. A general recommendation to screen 
for anxiety and depression (Perk et al., 2012) might have 
little benefit, as specific subtypes of depression differenti-
ate in predictive power, and the role of anxiety is far from 
conclusive. In research on the link between depression and 
CHD, more attention should be given to measurement 
issues and levels of specificity. Gender differences in 
depression are important to incorporate, as well as a focus 
on specific aspects of depression symptom clusters and dif-
ferent anxiety diagnoses. The results of this study suggest 
that it would be useful to develop gender-differentiated 
screening tools for depression in preventive CHD care 
and that the role of anxiety as a risk factor needs to be re-
evaluated or reversed.
Strengths and limitations
This study contributes to the existing literature in the fol-
lowing ways: (1) prospective study of a large community-
based sample free of CHD at baseline; (2) it includes all the 
major risk factors; (3) separate analysis is applied for men 
and women (4); two different measures of depression are 
included as potential screening tools; (5) it includes meas-
ures of anxiety; and (6) it includes both fatal and non-fatal 
MI as end-point measures.
The most obvious limitations in this study are as fol-
lows: (1) the reliance on self-reporting measures for several 
variables, and (2) the measure of depressive episode is 
unspecific, as it does not ask when it occurred or whether 
there have been recurrent episodes. Furthermore, a depres-
sive episode as described here does not imply a valid 
assessment of major depressive episode as diagnosed in the 
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Diagnostic and Statistical Manual of Mental Disorders 
(5th ed.; DSM-V). Although HADS has been found to be a 
reliable screening instrument of psychological stress, the 
factorial structure of HADS has been questioned (Martin 
et al., 2003).
This study indicates that men and women represent dif-
ferent populations in the investigation of psychological risk 
factors in the development of MI and that the association 
between depression, anxiety and CHD is gender specific. 
This study emphasizes the importance of screening for 
depression in women with no CHD at baseline. Symptoms 
of anhedonic depression measured by HADS-D might be a 
gender-specific risk factor of MI in women.
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